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ABSTRACT OF DISSERTATION

OXIDATIVE STRESS AND MITOCHONDRIAL DYSFUNCTION
IN TRAUMATIC BRAIN INJURY IN AGING
Traumatic brain injury (TBI) is a prominent disease in developed countries, and
age is an important factor in functional outcome. Although aged patients typically show
diminished recovery compared to young patients, and have higher mortality and
morbidity following TBI, the mechanism is not well understood. To date, there is no
effective therapeutic for TBI.
Previous studies indicate a secondary injury in TBI begins immediately after
impact, and is likely the major contribution to delayed neuron dysfunction and loss.
Studies also suggest mitochondrial dysfunction and increased free radical species (ROS)
production following TBI may play a key role in the process. To evaluate oxidative
damage following TBI, especially in aging, young (3 months), middle aged (12 months)
and aged (22 months) Fisher-344 rats were subjected to a unilateral controlled cortical
impact (CCI) injury, and tissue sparing, 4-hydroxynonenal (HNE) and acrolein levels,
and antioxidant enzyme activities, and DNA oxidative damage were measured. In order
to evaluate changes in mitochondria following TBI, mitochondrial protein levels were
investigated using young adult animals. To evaluate a potential therapeutic for TBI, the
effect of creatine on oxidative damage was evaluated.
These studies show an age dependent increase of oxidative damage following
TBI, demonstrated by increased levels of 4-HNE, acrolein and 8-hydroxyguanine. Middle
aged and aged animals showed increased tissue loss compared to young animals 7 days
post injury. Mitochondrial proteins involved in the respiratory chain, carrier proteins and
channel proteins were significantly decreased 24 h post injury in ipsilateral cortex, but
increased in both ipsilateral and contralateral hippocampus. To study potentially
protective compounds in TBI, animals were fed with creatine two weeks before TBI and
showed less oxidative damage and increased antioxidant capacity, which suggests
creatine may be a potential drug for clinical treatment of TBI.
The work described in this dissertation is the first to show increased oxidative
damage and diminished antioxidant capacity in TBI in aging. The study of mitochondria
following TBI using quantitative proteomics is also the first time to show multiple
mitochondrial proteins change following TBI. These data are also the first to show

creatine can increase antioxidant defenses. These studies contribute to our understanding
the mechanisms of secondary injury in TBI in aging.
KEYWORDS: Antioxidant Enzyme, Creatine, Oxidative Damage, Mitochondrial
Dysfunction, Traumatic Brain Injury
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CHAPTER ONE
Introduction and Background
1.1 Traumatic Brain Injury and Physiological Consequences
Traumatic brain injury (TBI), also called acquired brain injury or head trauma,
occurs when a sudden impact results in damage to the brain. TBI can result when the
head violently hits an object, or when an object pierces the skull and enters the brain. The
injury can be short term or long term. As a short term injury, patients with severe head
trauma may die immediately or experience coma for hours and days. Patients with
moderate or mild injury may experience a loss of consciousness for a few seconds or
hours. As a long term injury, TBI leads to neuron damage or death at the site of injury
and adjacent regions of brain, and can be a factor for such neurodegenerative disorder as
Alzheimer’s disease (AD) (Guo et al., 2000). Clinical studies reveal that survivors of TBI
may experience trouble in one or multiple areas, including thought and reasoning,
understanding words, remembering things, paying attention, solving problems, thinking
abstractly, talking, behaving, walking and other physical activities, seeing and/or hearing,
and learning (McAllister et al., 2006; Tombaugh et al., 2006; O'Keeffe et al., 2007).
TBI is the leading cause of injury-related death in developed countries (DasGupta and Turner-Stokes, 2002), accounting for 26% of all trauma-associated deaths in
the United States (Sosin et al., 1989; Sosin et al., 1995). TBI is also a major cause of
persistent functional disability and psychological impairment (Harvey, 1986). Recent
statistics show that motor vehicle accidents (~60%), falls, assaults and various sportsrelated injuries (40%) result in TBI that affects ~ 7 million individuals each year in North
America (Tibbs et al., 1998; McNair, 1999). Approximately 70,000 to 90,000 of those
injured suffer long-term disability. The cost to treat these individuals is estimated at ~
$20 to $25 billion annually (McIntosh et al., 1996). In the last 30 years, our
understanding of the physiopathology of TBI has greatly improved, but the mechanism of
injury, particularly delayed injury, is still unclear. The improved outcome of patients with
severe TBI has reached what looks like an unmodifiable plateau resulting from limited
understanding of the neurological and neurochemical cascades triggered by primary
mechanical injury. There is still no specific pharmaceutical therapy for TBI and further
studies are needed for more clues in clinical therapy.
1

1.2 Factors Affecting the Outcome of TBI
Several factors are believed to be important to the pathogenesis of TBI. Age is
one of the most widely investigated factors. Age-specific TBI associated death rates show
a bimodal distribution with peaks at 15- to 24-years of age and >75 years of age (Figure
1.1) (Sosin et al., 1989). Studies of TBI in young adulthood and elderly patients show
that very young and old patients are more severely damaged and less likely to recover
(Hoane et al., 2004; Kirkness et al., 2004; Testa et al., 2005; LeBlanc et al., 2006;
Thompson et al., 2006). Gender is believed to be another factor that may play a role in
TBI (Kovacs, 2005; Robertson et al., 2006). Males are 2 to 3 times as likely as females to
sustain TBI, especially during high-risk years (Thurman, 2001). The reason why age and
gender affect the outcome of TBI is still under debate. Genetic factors may also impact
TBI, particularly the presence of apolipoprotein E4 alleles (Diaz-Arrastia et al., 2003;
Nathoo et al., 2003; Diaz-Arrastia and Baxter, 2006). Additionally, preventive methods
are also important to limit TBI. For example, helmet and airbags can greatly reduce brain
injury.
1.3 Animal Models of Traumatic Brain Injury
Because of the limited availability of human TBI specimens, several animal
models that simulate human TBI have been developed in last several decades with new
models still under development.
For over a century, various in vivo models of TBI have been employed to
systematically produce pathology of TBI, including fluid-percussion (FP), controlled
cortical impact (CCI), and weight drop (Awasthi et al., 1997; Scheff and Sullivan, 1999;
Shimamura et al., 2004). In consideration of experimental design, the species of animal,
location of injury and choice of anesthesia are also considered. Cats (Bedell et al., 1998),
pigs (Pfenninger et al., 1989), rats (DeKosky et al., 2004), and mice (Hall et al., 2005) are
now commonly used animals in studies of TBI. The injury locations include midline for
whole brain concussion injury and parietal cortex for lateral percussion injury. For FP
injury, the injury is produced when a metal pendulum strikes the piston of an injury
device from a certain height leading to a pulse injection of saline into the closed cranium,
which

induces

a

brief

increase

2

of

intracranial

pressure

with

Age specific rates for head injury-associated death,
by underlying causes, United States, Annualized for 1979 to 1986
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Figure 1.1. Death rate distribution of TBI in aging (Sosin et al., 1989).
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associated displacement and deformation of brain tissue. The severity of injury is
controlled by the height of the pendulum. The FP injury was first described by Linden
and Ringer (1965) using a rabbit model of TBI (Carbonell et al., 1998). This model
produces concussive injury, hippocampal cell death and cortical contusion, vascular and
blood-brain

barrier

disruption

injury,

cerebral

edema,

tissue

shearing,

and

intraparechymal hemorrhage. The CCI model, which allows better control of the
biomechanical parameters of injury leading to reproducible injuries, was first introduced
by Lighthall and colleagues (Lighthall, 1988). The injury is easier to quantify by
regulation of the impact force, velocity and dwell time and to measure the tissue
deformation and functional impairment. In the CCI model, a cylinder is used with a round
or flat edge, and is pneumatically driven to produce injury. Like the FP injury, the CCI
model also produces injury that resembles certain aspects of human TBI, but it produces
a significantly more pronounced cortical contusion. Another injury model is the weight
drop model, which can be used with either an open or closed skull. Injury with an open
skull produces a focal lesion that progresses from hemorrhages in the white matter to a
necrotic cavity. A closed skull injury produces a diffuse injury without noticeable
contusions or hippocampal cell loss. In this model, a weight is released through a guide
tube and subsequently strikes a footplate resting directly on the exposed brain or directly
on a cemented disk on the skull. The severity of injury is controlled by the weight and
distance the weight travels.
1.4 Current Understanding of Mechanism of TBI
TBI is a result of direct and indirect brain damage, resulting from primary
mechanical injury and secondary injury. Primary mechanical injury can be reduced or
avoided through protective measures, such as education of potential victims and use of
safety equipment (helmets, airbags). In TBI, primary mechanical brain injury happens in
seconds, resulting in subdural hematoma, laceration, diffuse axonal injury, diffuse
vascular injury, intracerebral hemorrhage, and concussion (BIROS, 1998a; Armin et al.,
2006). With current technology, it is believed that the brain damage from mechanical
injury is irreversible. Secondary injury follows primary mechanical injury in minutes,
hours and days, and is potentially treatable (Hall et al., 2005).

4

Previous studies show secondary injury results in delayed dysfunction and death
of neuronal populations near and distant to the site of injury. Neuron death resulting from
secondary injury is complicated, and the pathogenesis is unclear. However, It has been
shown neuron death involves both cell apoptosis and necrosis (Raghupathi, 2004). There
are some contributors to the cellular apoptosis and necrosis, including excess excitatory
amino acids, mitochondrial dysfunction, oxidative damage, and adenosine and
triphosphate adenine nucleotide depletion, inflammatory events, ion homeostasis
disruption, proteolytic enzyme activation, DNA damage, and cholinergic receptors
dysfunction (Simon et al., 1984; Azbill et al., 1997; Sullivan et al., 1998; Tyurin et al.,
2000; Verbois et al., 2002; Mendez et al., 2004; Lu et al., 2005; Cimatti, 2006). This
dissertation is focused on studies of oxidative damage and mitochondrial dysfunction in
TBI.
1.4.1 Mitochondrial Dysfunction in Aging and TBI
Mitochondria, believed to have originated from evolution of bacteria having a
symbiotic relationship with ancient eukaryotic cells, are the power house of eukaryotic
cells (Margulis, 1981). As the power supply, mitochondria synthesize ATP and consume
molecular oxygen by reducing O2 to H2O in oxidative phosphorylation. Structurally,
mitochondria consist of an outer membrane, an inner membrane, the intermembrane
space and the matrix. However, mitochondria have different shapes and population
densities in different cells (Figure 1.2) (Perkins and Frey, 2000; Scheffler, 2001). The
inner membrane folds into cristae to increase the inner membrane area, and is relatively
rich in protein, consisting of ~ 75% protein and 25% lipids (DePierre and Ernster, 1977).
One third of mitochondrial proteins, including complexes I, II, III IV and V, adenosine
triphosphate (ATP) and ion translocators, are involved in the respiratory chain and ATP
syntheses. The lipids of the inner membrane are predominantly phospholipids, including
phosphatidylcholine, phosphatidylethanolamine and cardiolipin (Ardail et al., 1990;
Camici and Corazzi, 1995; de Kroon et al., 1997). The outer membrane contains receptor
proteins, signaling proteins, and channel proteins, including the Bcl-2 family of proteins,
hexokinase, and voltage-dependent anion channel (VDAC) proteins (Adams and Cory,
1998; Verrier et al., 2003; McBride et al., 2006). The outer membrane is permeable to
both charged and uncharged molecules with a molecular mass less than 1000 Daltons

5

(Verrier et al., 2003). Ketones, mitochondrial DNA and the enzymes and cofactors
associated with Krebs cycle, amino acid metabolism and fatty acid oxidation and
synthesis, and mitochondrial protein folding are located in the matrix. Although
mitochondria have their own circular DNA, only 13 polypeptides are encoded by
mitochondrial genes, including seven subunits of complex I, one subunit of complex III,
three subunits of complex IV, and two subunits of the H+-translocating ATP synthase
(Scheffler, 2001). There are thousands of mitochondrial proteins encoded by nuclear
DNA, which are transferred to mitochondria by transporting proteins (Neupert, 1997;
Pfanner, 1998; Schatz, 1998).
Mitochondria serve not only as power house, but also as a calcium sink to control
ion homeostasis through two modes of calcium influx and two of efflux as well as
through calcium induced formation of the MTP. The most studied Ca2+ influx mechanism
is the uniporter that transports Ca2+ through its electrochemical gradient without coupling
the transport to other ions or molecules. Another Ca2+ influx mechanism is the ‘rapid
mode’ or RAM (Gunter et al., 2000). Calcium efflux pathways include Na+-dependent
and Na+-independent mechanisms (Crompton et al., 1977; Crompton et al., 1978;
Murphy and Fiskum, 1988). In addition, mitochondria play a key role in cell signaling,
regulating cell survival via apoptosis involving Bcl-2 family protein, cytochrome c and
caspase 9 and 3, and apoptosis-inducing factor (AIF) (Liu et al., 1996; Danial et al., 2003;
Saelens et al., 2004).
Glycolysis is an alternative energy production process in cells. Under aerobic conditions,
glycolysis can produce ATP, NADH and pyruvate. NADH can be transported by the
glycerol phosphate shuttle or the malate-aspartate shuttle to mitochondria for oxidative
phosphorylation. Pyruvate is the initial substance in the Krebs cycle for NADH, FADH
and GTP production. Therefore, glycolysis and mitochondrial oxidative phosphyorylarion
are closely connected with each other. Hexokinase locates in mitochondrial outer
membrane and catalyzes ATP-dependent phosphorylation of glucose to form glucose-6phosphate, and it is also a key protein in mitochondrial permeability transition pore
(Robey and Hay, 2006).
The mitochondrial respiratory chain is the major intracellular source of reactive

6
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oxygen species and free radicals under normal physiologic and pathologic conditions.
Mitochondria play a key role in aging since they appear to be particularly susceptible to
damage, as evidenced by dramatic declines in respiratory function, mitochondrial
transcripts, cytochrome c oxidase activity and ATP production (Calleja et al., 1993;
Schwarze et al., 1998). Respiratory chain damage, particularly complex I and IV, are
widely measured to evaluate mitochondrial function (Navarro and Boveris, 2007). Using
electron microscopy, structurally abnormal mitochondria are observed to accumulate
during aging (Miquel et al., 1976; Fleming et al., 1985). The “mitochondrial theory of
aging” postulates that damage to mitochondrial DNA (mtDNA) by free radicals leads to
loss of mitochondrial function and loss of cellular energy (Cortopassi and Wong, 1999).
Human mtDNA consists of 16,569 base pairs with 37 genes. Unlike nuclear DNA,
mtDNA has limited protection, and is more easily damaged. In addition, mtDNA repair is
less efficient than nuclear DNA. Accumulated mtDNA damage could lead to mutations
and disrupt the mitochondrial protein expression. In addition to damage to mtDNA, free
radicals can oxidatively damage proteins. For instance, oxidatively damaged aconitase
and adenine nucleotide transporter (Yan et al., 1997; Yan and Sohal, 1998) have been
shown to accumulate during aging. In addition, free radicals oxidize unsaturated fatty
acids and could compromise the integrity of mitochondrial membranes and alter
permeability. Changes in mitochondrial permeability could lead to structure changes,
leakage of protons and membrane associated proteins, and reduce mitochondrial
potential, resulting in compromised the energy production. The reduced mitochondrial
function and ATP production would decrease the rate of protein synthesis and turnover,
which in turn could increase protein half-life and the potential for further damage.
It has been shown that mitochondria play a key role in chronic and acute
neurodegenerative disorders except aging, including

Parkinson’s disease (PD), AD,

amyotrophic lateral sclerosis (ALS), ischemic brain injury, and stroke (Kristian and
Siesjo, 1998). Studies of these diseases show damaged mitochondrial proteins and DNA,
disrupted signal processing, increased oxidative stress and reduced Ca2+ buffer capacities,
impairment of respiratory chain function and other enzymes (Xiong et al., 1997b; Fiskum
et al., 1999; Lifshitz et al., 2004; Chen et al., 2006; Kaddour-Djebbar et al., 2006).
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Studies of mitochondrial dysfunction in TBI have been limited. The role of
mitochondria in neuron damage following TBI is unclear. Previous studies show
metabolic disruption occurs following TBI (Yoshino et al., 1991; Ginsberg et al., 1997)
as evidenced by reduced capacity to produce glutamine in mitochondria (Ashwal et al.,
2004). The reduced capacity to regenerate glutamine from glutamate in astrocytes could
lead to excess glutamate in the synaptic cleft, lead to overactivation of ion channels, and
disrupt ion homeostasis of neurons. In addition, mitochondria show reduced sequestration
capacity of calcium as early as 3 h post injury (Singh et al., 2006) and provoke cell death.
C.P. Lee and coworkers (Xiong et al., 1997b), using a controlled cortical impact model,
also demonstrated considerable impairment of brain mitochondrial respiration following
injury. Previous research from Hall et al. showed mitochondrial respiration is damaged
as early as 30 mins post injury (Singh et al. 2006), and other studies showed respiratory
damage persisted for up to 14 days following injury (Xiong et al., 1997b). The
compromised respiration could reduce the ATP production and could significantly affect
the function of ATP dependent enzymes. Significant ATP shortage could lead to cell
necrosis. Additionally, contact proteins between the inner membrane, outer membrane
and intermembrane space form channels called mitochondrial permeability transition
(MPT) pores and trigger cell death under oxidative stress or excess calcium loading.
Alterations in mitochondria could trigger free radical leakage and apoptosis through
cytochrome c release from the mitochondria (Sullivan et al., 2002). Lipid peroxidation
and mitochondrial protein modifications by reactive oxygen species were shown to be
significantly increased following severe injury (Singh et al., 2006), and indicate free
radicals play a role in mitochondrial dysfunction in TBI. In addition, uncoupling proteins
are shown to play a pivotal role in cell survival and to be interrupted in TBI (Mattiasson
et al., 2003; Sullivan et al., 2004), and the uncoupling protein inhibitor could reduce the
mitochondrial damage. Although previous studies show mitochondrial damage in TBI,
there has been little study of changes in protein expression in mitochondria. are not clear.
Additionally, the mitochondria are damaged during aging, and respond differently to
injury in aged animals compared with young animals. The studies described here help
elucidate the different response of mitochondria in aging and may help explain the
exacerbated mitochondrial defecits observed in aged patients.
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1.4.2 Oxidative Stress
Oxidative stress is a condition in which the balance between antioxidant defenses
and reactive oxygen species (ROS) generation is disrupted, and favors ROS accumulation
(Braughler and Hall, 1989). These ROS include superoxide radicals (O2•−), hydrogen
peroxide (H2O2), hydroxyl radicals (OH.), lipid oxyl or peroxyl radicals (ROO·), singlet
oxygen, and peroxinitrite (NOOO-), which behave as a unit and are now named “free
radicals”(Valko et al., 2007). The original oxidative species in vivo is partly reduced
superoxide (O2·−) and nitric oxide (NO). Free radical species contain unpaired electrons
in their atoms, and are very chemically reactive.
Mitochondria are the major source of superoxide radicals, although other enzymes
such as xanthine oxidase and NADH peroxidase are also contributors (Antoine et al.,
2006; Valko et al., 2007). It is estimated that 70-80% of O2·− from mitochondria is
vectorially released to mitochondrial matrix and 20-30% to the intermembrane space
(Navarro and Boveris, 2007). The two major O2·− production reactions have been
described

as

auto-oxidation

of

intermediate

semiquinones:

UQH·

for

the

ubiquinone/ubiquione redox pair (UQH· + O2 →UQ + H+ + O2·−) (Boveris and Chance,
1973) and the FMN• of the FMNH2/FMN coenzyme of NADH dehydrogenase (FMNH• +
O2 → FMN + H+ + O2·−) (Turrens and Boveris, 1980).

The reactions are

nonenzymatically oxidized by molecular oxygen to yield superoxide.
Iron is one of the most abundant metal ions in humans. Iron is a late transition
metal and has two oxidation states (+2 and +3). Fe2+ is a reducing reagent and Fe3+ is an
oxidizing agent Iron is generally incorporated into the heme complex. In most organism,
heme is an essential component of cytochrome proteins, which mediate redox reactions,
and of oxygen carrier proteins such as hemoglobin and myoglobin. Iron toxicity occurs
when there is free iron in the cell, which generally occurs when iron levels exceed the
capacity of transferrin to bind the iron. Iron is involved in ROS production of superoxide,
and hydroxyl radicals by Fenton’s reaction (Figure 1.3) (Braughler et al., 1986), in which
Fe2+ is oxidized to Fe3+, and H2O2 is reduced and decomposed to form hydroxyl radical.
Fe3+ can be reduced by superoxide to regenerate Fe2+. Free radical damage is a major
theory of aging and neurodegenerative diseases. This theory of aging postulated by
Denham Herman suggested that free radical damage and the accumulation of the
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Fe(III) + Reductant

Fe(II) + oxidant

Fe(II) + O2

.Fe(III) + O2

.2O2 + 2H+

H2O2 + O2

Fe(II) + H2O2

Fe(III) + OH - + OH.

superoxide dismutation

Fenton's reaction

Figure 1.3. Iron is the most abundant transition metal ion in brain, and is derived from
hemoglobin or transfer protein release. Increased iron exposure leads to increased
oxidative damage. The most important reaction in the formation of OH• is the Fenton’s
reaction, which was established in 1894.
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oxidative damage is the cause of cell death, organ dysfunction and aging (Harman, 1972).
It is suggested the ability of cells to detoxify ROS and replace oxidatively damaged
macromolecules is apparently inefficient over time, as oxidative damage products
accumulate in every aging organism examined. Previous studies show significantly
increased superoxide in brain in aging, and superoxide levels in hippocampus are higher
than in cortex or striatum (Antier et al., 2004). Superoxide and other free radicals with
unpaired electrons can damage polyunsaturated fatty acids (arachidonic acid and
decosohexaenic acid), DNA and proteins, resulting in formation of toxic aldehydic
products (Figure 1.4) and oxidized DNA bases, protein thiol loss, protein cross linking,
protein and DNA cross linking, and protein or DNA adducts with aldehyde products of
lipid peroxidation (Braughler and Hall, 1989). As the major source of ROS, mitochondria
appear to be also a key target of oxidative damage during aging (Nicholls, 2002;
Lesnefsky and Hoppel, 2003). Previous studies show increased lipid peroxidation
products, DNA oxidation products and abnormal proteins in aging (Sohal et al., 1995;
Schwarze et al., 1998; Orr et al., 2003), and that mitochondrial DNA are more severely
oxidatively damaged than nuclear DNA (Wang et al., 2003).
Lipid peroxidation products are stable markers of membrane lipid damage and
oxidative stress. Studies of lipid oxidation can be traced back to the 1940’s when it was
shown that hydroperoxides are the primary products of hydrocarbon oxidation (Farmer et
al., 1942). Detailed studies of products of polyunsaturated fatty acid oxidation were
initiated in the 70's, and the first demonstration of free radical oxidation of membrane
phospholipids was in 1980 (Porter et al., 1980a, b). Many lipid peroxidation products
have been identified, including primary products such as F2-isoprostanes and
hydroperoxides of oleic acid, linoleic acid, and other highly unsaturated fatty acids like
arachidonic acid. These primary products could be oxidized to secondary products, such
as 4-hydroxy-2-nonenal (Schneider et al., 2001), 4-hydroxy-2,3–hexenal, acrolein, and
malondialdehyde (MDA). Previous studies show increased lipid peroxidation following
TBI, including significant elevations of thiobarbituric acid reactive substances (TBARS)
and 8-isoprostaglandin F2α in injured cortex (Hoffman et al., 1996; Hsiang et al., 1997).
Recently, 4-hydroxynonenal (HNE) and acrolein, two neurotoxic byproducts of lipid
peroxidation of arachidonic acid (Benedetti et al., 1980), have become of interest in a
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O

variety of neurological diseases (Lovell et al., 1997; Lovell et al., 2000). HNE levels
were shown to be significantly increased in brain and spinal cord injury (Baldwin et al.,
1998; Zhang et al., 1999; Cao et al., 2001; Hall et al., 2004; Singh et al., 2006) in young
animals, although the lipid peroxidation in TBI in aging remains unclear.
HNE and acrolein are most toxic byproducts of lipid peroxidation. It is well
established that HNE and acrolein can modify proteins, DNA/RNA in vivo and in vitro,
and these modifications could lead to protein dysfunction (Hiratsuka et al., 2000;
Akagawa et al., 2006). Previous studies show HNE modification can lead to dysfunction
of oxidative phosphorylation complexes, Na+/K+-ATPase, NADP+-dependent isocitrate
dehydrogenase, proteasome, and cathepsin B (Siems et al., 1996; Okada et al., 1999;
Crabb et al., 2002). In addition, HNE can improve AP-1 binding activity (Camandola et
al., 2000) and trigger apoptosis (Bruckner et al., 2003), leading to neuron death and tissue
loss in injured animals. Additionally, HNE can trigger an epidermal growth factor
receptor-linked signal pathway for growth inhibition by phosphorylation of adaptor
protein Shc and activation of MAP kinase (Liu et al., 1999). It has also been shown that
HNE can induce the heat shock protein factor and upregulate the heat shock protein
expression in cell culture (Cajone, 1988), triggering cell defense. A small number of
studies show lipid peroxidation increases immediately after TBI and is maintained for
several days (Hall et al., 2004).
When ROS are produced close to DNA, it can result in DNA damage. It is
suggested that hydroxyl radicals generated from hydrogen peroxide are extremely active
with a life time of ~10-6 s, and can react close to its formation (Pastor et al., 2000). DNA
oxidation includes damage to base and sugar moieties, leading to DNA strand breaks,
gene mutation and cell apoptosis (Chen et al., 1997; Johnson et al., 2005). Currently,
about 20 DNA base oxidative products have been identified. For example, oxidized
guanine in DNA by reactive oxygen species leads to formation of 7,8-dihydro-8oxoguanine

(8-OHG),

and

ring

opening

products

2,6-diamino-4-hydroxy-5-

formamidopyrimidine (fapyguanine, FG). Adenine oxidative products include 8hydroxyadenine (8-OHA) and 4,6-diamino-5-formamidopyrimidine (fapyadenine, FA).
For cytosine and thymine, oxidative damage results in formation of 5-hydroxycytosine
(5-OHC), 5,6-dihydroxycytosine, 5-hydroxy-6-hydrothymine and thymine glycol. The
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DNA base oxidative products can be used as markers to evaluate the oxidative damage in
cell. The effect of oxidative stress in DNA damage has been studied extensively in aging,
cancer, AD, HD, diabetes and stroke, but limited in TBI (Alam et al., 1997; Rehman et
al., 1999; Nagayama et al., 2000; Wang et al., 2005). The accumulation of free radical
induced damage to DNA is illustrated by an age-related increase in human serum over an
age range of 15-91 years (Valko et al., 2007). Numerous studies have reported the
accumulation of 8-OHG and other lesions with age, both in vivo and in vitro, in nuclear
and mitochondrial DNA. Although 8-OHG levels are increased in injured brain cortex in
TBI in young animals(Mendez et al., 2004), it is unclear whether DNA oxidative damage
is exacerbated in TBI in aging. In order to evaluate DNA oxidative damage in TBI in
aging, 8-OHG, FG, 8-OHA, FA, and 5-OHC are oxidized bases investigated in this
dissertation (Figure 1.5).
1.4.2.1 Mechanism of Lipid Peroxidation
Unsaturated fatty acids, especially ω-3 such as linoleic acid, and ω-6, including
arachidonic (AA, 20:4n-6), docosatetraenoic acid (DCS, 22:4n-6) and decosohexaenic
acid (DCH, 22:6n-6), are major components of cell membranes and organelles. These ω6 fatty acids are abundant in brains and highly susceptible to free radical attack. Lipid
peroxidation forms a variety of products, including malondialdehyde, 4-hydroxynonenal,
acrolein, and other aldehydes (Williams et al., 2005). The mechanism of lipid
peroxidation in vivo is difficult to investigate because of the complicated cellular
environment. However, studies in organic chemistry help suggest possible pathways of
lipid peroxidation. Using arachidonic acid and linoleic acid as substrates, their
autoxidation and enzyme catalyzed oxidations were investigated. Arachidonic acid or
linoleic acid may be attacked by free radicals and lose hydrogens attached to bis- allylic
carbons (Thomas and Pryor, 1980). Oxygen can then add to allyl radicals and form
peroxyl radicals. The peroxyl radical may abstract hydrogen from hydrogen donor
forming hydroperoxide. Hydroperoxides are precursors of products such as 4-HNE and
acrolein (Porter et al., 1981). In arachidonic acid autoxidation, six major conjugated diene
hydroperoxide, hydroperoxyeicosatetraenoic acids (HPETE), have been identified (Porter
et

al.,

1979),

and

all

have

trans,cis
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with hydroperoxide substitution being at carbon 5, 8, 9, 11, 12, or 15. Further
oxygenation can form dihydroperoxides, which fragment to 4-hydroperoxy-nonenal by
Hock rearrangement.

4-Hydroperoxy-nonenal could form 4-hydroxynonenal (Figure

1.6). The mechanism for acrolein formation from unsaturated fatty acids is not well
investigated yet. It’s possible the formation of acrolein follows a different mechanism.
1.4.2.2 Mechanism of DNA Oxidation
Free radicals attack of the DNA strand leads to DNA base and ribose moiety
oxidation. The attack of ribose could lead to strand break and DNA fragmentation.
Damage to DNA bases could result in a variety of base oxidation products. However,
radicals have a high preference for interaction with the base part of the molecule rather
than with the ribose (phosphate) (O'Neill and Davies, 1987). The addition of OH• to
purines could form C4-OH, C5-OH, and C8-OH products. The C8-OH adducts of purines
could form 8-OHG, FG, 8-OHA, and FA products (Figure 1.7). As for pyrimidine base,
hydroxyl radical (OH·) could attack C5 and C6 to from cytosine glycol, which dehydrates
to form 5-OHC (Figure 1.8). Among the bases, guanine is the most easily oxidized,
which is supported by MO calculation, ionization potential, and aqueous-phase redox
(Jovanovic and Simic, 1986; Steenken, 1989).
1.5 Antioxidant Enzymes
Exposure to free radicals from a variety of sources has led to development of a
series of defense mechanisms. Defense mechanisms against free radical-induced
oxidative stress include: preventive mechanisms, repair mechanisms, physical defenses,
and antioxidant defenses. Non-enzymatic antioxidants incude ascorbic acid (Vitamine C),
alpha-tocopherol (Vitamine E), glutathione (GSH), carotenoids, flavonoids, and other
antioxidants. Antioxidant enzymes include superoxide dismutase (Cu/ZnSOD and
MnSOD), catalase and glutathione peroxidase (GPx), glutathione reductase (GSSG-R),
and glutathione transferase. These enzymes work in concert to protect cells (Figure 1.9).
1.5.1 Superoxide Dismutase (SOD)
SOD, a metalloenzyme was first discovered by McCord and Fridovich (McCord
and Fridovich, 1969). SOD catalyzes the dismutation of toxic superoxide radicals with
the conversion of hydrogen ions to hydrogen peroxide, which is less toxic. It has been
established that all organisms living in the presence of oxygen have at least one form of
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SOD, with an active site containing manganese, iron, nickel or copper-zinc (Cadelli et al.,
1999; Niviere and Fontecave, 2004). Manganese (Mn) and copper-zinc (Cu/Zn)
dismutases are present in human and animals. MnSOD (MW 26.6 KDa) is located in
mitochondrial matrix, and Cu/ZnSOD (32 KDa) is found in cytosol, mitochondrial
intermembrane space and extracelluar fluid. The gene encoding SOD human mRNA
resides on chromosome 21.
SOD plays a key role in antioxidant defense. Cu/ZnSOD activity decreased in
stroke, SOD protein and gene transcription levels, and the enzyme activity are
investigated have been widely investigated in a variety of neurodegenerative diseases,
including ALS, AD, PH, spinal and brain injury (Trotti et al., 1999; Demirkaya et al.,
2001; Earnhardt et al., 2002; Antier et al., 2004; Vaziri et al., 2004). Transgenic animals
with increased expression of SOD show increased life span and less damage following
ischemic injury (Saito et al., 2003). SOD mimetics were reported to be effective in
attenuating oxidative associated neurodegenerative disease.
1.5.2 Glutathione Peroxidase and Catalase
As mentioned above, superoxide dismutase catalyzes the dismutation of
superoxide radical (O2•−) to produce hydrogen peroxide (H2O2), a quite stable and
invasive ROS. Moreover, through the Fenton and Haber-Weiss coupled reactions, H2O2
forms reactive hydroxyl radical (OH•). To efficiently remove hydrogen peroxide, two
antioxidant enzymes are available: catalase and GPx, which both transform H2O2 into a
harmless product, H2O. These two enzymes do not work in identical conditions although
they do similar jobs. First, catalase only uses H2O2 as a substrate, whereas GPx uses both
H2O2 and lipid peroxides as substrates (Cohen and Hochstein, 1963). Catalase functions
when H2O2 concentrations are significantly above physiological levels that can occur in
oxidative bursts characteristic of stress responses. However, GPx functions during small
variations of H2O2 concentrations (Drevet, 2006). Therefore, GPx activity represents the
first protective response for small adjustments in H2O2 concentrations under normal
physiological conditions. Glutathione peroxidase also needs glutathione as a substrate, in
which reduced glutathione (GSH) is converted to oxidized form (GSSG).
Glutathione peroxidase is a family of proteins, divided into five classes (GPx1 to
GPx5) (Chu, 1994) based on their primary sequence, substrate specificity and subcellular
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localization. GPX1, the so-called cytosolic or cellular GPx, was the first GPx to be
discovered (Mills, 1957), and is abundant in kidney, lung, red cells and liver, but
relatively low in brain. GPx2, another cytoplasmic enzyme, exists in stomach and
intestines (Chu et al., 1993).

GPx3, an extracellular GPx or plasma-type GPx (pGPx),

was found to be preferentially expressed in the mammalian kidney with lower levels in a
wide array of tissues (Maser et al., 1994; Schwaab et al., 1998). GPx4, also called
phospholipid hydroperoxide glutathione peroxidase (PHGPx), is a membrane-associated
GPx expressed in the mammalian testis, brain and heart (Ursini et al., 1982). GPX5, also
previously known as MEP24 (for mouse epididymal protein of 24 KDa) or epididymal
GPX (epGPx), is a highly restricted GPx and is expressed only in the mammalian caput
epididymidis (Ghyselinck and Dufaure, 1990). In higher animals, GPxs are seleniumcontaining proteins. They contain a selenocysteine residue, which form so-called catalytic
triad with glutamine and tryptophan residues (Maiorino et al., 1995).
1.5.3 Glutathione Reductase
Glutathione, a triamino acid peptide (γ-glutamylcysteinylglycine), is an
antioxidant molecule, and also functions in DNA and protein synthesis regulation, signal
transduction, cell-cycle control, proteolysis, immune response and cytokine synthesis
(Harding et al., 1996; Wu et al., 2004). The synthesis of GSH is catalyzed by γglutamylcysteine synthetase (GCS) and GSH synthetase. GCS activity, cysteine
availability, and GSH feedback inhibition are the main factors regulating GSH synthesis.
In addition, recycling of oxidized GSH produced by GPx is important in the maintenance
of reduced GSH levels in the cell. Glutathione reductase is the enzyme that converts
oxidized GSH (GSSG) back to reduced GSH, and is involved in the pathogenesis of
many diseases. The conversion from GSSG to GSH requires NADPH, which is produced
from reactions catalyzed by glucose-6-phosphate dehydrogenase and 6-phosphogluconate
dehydrogenase. GSSR-R is important not only for maintaining the required GSH level
but also for reducing protein thiols to their native state (Ganea and Harding, 2006).
1.5.4 Glutathione Transferase
Glutathione transferase (GST) is a family of detoxification enzymes that catalyze
the conjugation of glutathione (GSH) to a wide variety of xenobiotics (McIlwain et al.,
2006). GST isoforms contain a highly conserved N-terminal domain which has a
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catalytically active tyrosine, cysteine or serine residue. The catalytic residue interacts
with the thiol group of GSH (G-site), and the substrate binding site (H-site) near the Gsite to facilitate catalysis (Dirr et al., 1994; Armstrong, 1997). The detoxification ability
of GST plays a role in cellular protection from environmental and oxidative stress.
Human GSTs are divided into three main families: cytosolic, mitochondrial and
membrane-bound microsomal.
1.5.5 Antioxidant Capacity in Aging and Neurodegenerative Diseases
Aging is correlated with a reduced redox state and diminished antioxidant
capacities. Reducing equivalents, especially glutathione, are involved in maintaining
redox balance throught the cell. Reduced antioxidant defenses could change the redox
condition of cells. Many proteins contain redox-sensitive regulatory amino acid residues.
The reduced levels of glutathione could lead to the inactivity of redox sensitive proteins
(Kim et al., 2002; Droge, 2003). Aging studies using mice showed a 40% increase in
median life span and a 17% increase of maximal life span with supplementation with
Vitamine E (Navarro et al., 2005). Studies of Cu/ZnSOD show increased activity as a
function of age in brain, although other studies show the Cu/ZnSOD decreased in cortex,
hippocampus, and striatum in aged animals compared with young animals, which could
contribute to the increase of superoxide in aging (Antier et al., 2004). Additionally,
studies show no significant changes of Cu/ZnSOD and catalase levels among age groups
of 35-39, 50-54, and 65-69 years (Barnett and King, 1995). Because of the ability to
convert very active superoxide to less active hydrogen peroxides Cu/ZnSOD can reduce
the damage to DNA, RNA, protein, and unsaturated fatty acids. However, SOD defense
appears unable to keep pace with endogenous and exogenous sources of damage even
though antioxidant enzyme levels are unchanged or increased, leading to progressive
deterioration of structure and function with age. In neurodegenerative disease,
Cu/ZnSOD mutantions lead to oxidative damage, and associated with diseases such as
ALS (Trotti et al., 1999). MnSOD, a mitochondrial SOD, reduces the potential damage to
mitochondrial proteins and mtDNA. MnSOD expression is down regulated in smooth
muscle cells (Li et al., 2006), and human granulosa cells (Tatone et al., 2006), and could
contribute to their dysfunction in aging. In brain, MnSOD activity decreases linearly
upon aging (Navarro et al., 2002). It has been shown that partial MnSOD deficiency (+/-)
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results in mice with increased mitochondrial damage during aging (Wallace, 2002).
However, other studies indicate no significant changes in brain in aging (Antier et al.,
2004).
In AD, elevated SOD, catalase, GPx and GSSG-R and decreased GST activities
were reported, indicating a compensationary response in disease for most antioxidant
enzymes (Lovell et al., 1995; Lovell et al., 1998). In spinal cord injury, Azbill et al.
showed SOD was unchanged following injury (Azbill et al., 1997). In TBI, Dekosky et
al. showed SOD activity decreased, GPx and catalase increased significantly following
injury in young animals (DeKosky et al., 2004). However, the response of antioxidant
enzymes has not been investigated in TBI in aging.
1.6 Measurement of Oxidative Damage
Oxidative damage is widely investigated in a variety of diseases, including
cancer, AD, HD, diabetes, ALS, aging, stroke, cardiovascular disease, and TBI. There are
several methods to evaluate oxidative stress in vivo and in vitro, including measurement
of the reducing capacity of tissue or cell (Shohami et al., 1999); trapping the superoxide
radicals using electron spin resonance trapping reagents (Awasthi et al., 1997); measuring
products of oxidative stress such as lipid peroxidation (Hsiang et al., 1997) and DNA
oxidation (Mendez et al., 2004) or protein modification (Chirino et al., 2006). Measuring
lipid peroxidation byproducts, DNA oxidation markers, and protein carbonyls are
currently the most commonly used methods.
1.6.1 Analysis of By-products of Lipid Peroxidation
The measurement of markers of lipid peroxidation can be carried out using
fluorescence spectrometry, chromatography, and immunochemistry (Awasthi et al., 1997;
Hsiang et al., 1997; Lovell et al., 1997; Lovell et al., 2000; Hall et al., 2004; Davis et al.,
2006). Immunochemistry methods include Western blot, dot blot, slot blot and tissue
section staining. Immunochemistry measures the protein-bound lipid peroxidation
byproducts, which look at the protein modifications under oxidative stress (Springer et
al., 1997). Chromatography and fluorescence spectrometry methods quantify the free or
unstable protein-bonded lipid peroxidation byproducts in vivo. For example, using
fluorescence method, MDA, HNE and acrolein can be measured following derivatization
(Ohkawa et al., 1979; Lovell et al., 1997; Lovell et al., 2001).
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1.6.2 DNA Oxidation Analysis
DNA oxidative damage is widely investigated as a major marker of oxidative
damage in a variety of diseases (Loft and Poulsen, 1996; Kowalczyk et al., 2004; Mendez
et al., 2004). Various chemical and biochemical methods have been proposed, including
indirect measurements based on the use of antibodies (Mendez et al., 2004), single-cell
gel electrophoresis (Collins et al., 1995), 32P-postlabeling assays (Cadet et al., 1992), and
direct analysis by HPLC (Kasai, 1997) and GC/MS (Dizdaroglu and Bergtold, 1986). The
direct approach involves isolation of DNA, followed by hydrolysis for nucleosides or
nucleobases of DNA sample. The indirect methods are usually highly sensitive, but their
specificity is still open to debate. High performance liquid chromatography associated
with electrochemical detection (HPLC-EC) and gas chromatography coupled to mass
spectrometry (GC/MS) have been the most widely applied methods during the last decade
with detection limit of 50 fmol of oxidized base, which corresponds to one lesion per 106
normal base or in a DNA sample size of 10 pg. HPLC-EC assays are aimed at monitoring
the formation of oxidized bases with a low oxidation potential. The assay was initially
developed for the measurement of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-OHG) (Floyd
et al., 1986), and then extended to 8-oxo-7,8-dihydro-2'-deoxyadenosine (8-OHA)
(Berger et al., 1990), 5-hydroxy-2'-deoxycytidine and 5-hydroxy-2'-deoxyuridine, 5hydroxy-2'-deoxyuridine, and 5-hydroxy-2'-deoxycytidine (Wagner et al., 1992).
However, one limitation of HPLC-EC deals with the fact that only bases with a
low oxidation potential can be measured by electrochemical detection. In contrast,
GC/MS is a more versatile technique since it is less dependent on the chemical properties
of the oxidized base of interest (Dizdaroglu, 1991). The mass spectrometer may be set in
the selective ion monitoring (SIM) mode that detects only the ions corresponding to the
major peaks of the mass spectrum of the bases, which provides a more specific and
sensitive detection. One point that should be noted is the bases have to be derivatized into
volatile compounds prior to their injection into the GC/MS. In the current method, staple
isotopically enriched internal standards, which differ from the oxidized DNA bases in
samples by three units of mass, are used. Internal standards could reduce errors from the
derivatization step and also compensate for the possible lack of reproducibility of the
injection. The GC/MS assay was first applied to the detection of 8-OHG in isolated DNA
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that was exposed to γ-radiation in aqueous solution (Dizdaroglu, 1985). Subsequently, the
method has been applied numerous times to the measurement of many types of oxidative
base damage in isolated DNA (Aruoma et al., 1989; Spencer et al., 1994; Fuciarelli et al.,
1995; Wang et al., 2005) and within isolated cells (Djuric et al., 1991).
1.6.3 Protein Carbonyl Modification and Nitration Analysis
Under oxidative stress, proteins are targets of reactive oxygen species and lipid
peroxidation byproducts. Modification of thiol group on amino acid side chains can
result in loss of protein folding and incorrect folding (de Venevelles et al., 2006).
Aldehydic products of lipid peroxidation can react with amine groups to form Shiff base
adducts or react with cysteine to form Michael addition products (Hashimoto et al.,
2003). The peroxynitrite can modify tyrosine to inactivate proteins (Chirino et al., 2006;
Tao et al., 2006). Protein carbonyl and nitration can be measured using
immunochemistry, immunohistochemistry and mass spectrometry (Hall et al., 2004;
Matters et al., 2006).
1.7 Proteomics
Currently, biologists try to understand the function of cell at the molecular level
and to look for biological markers in cells with disease. Over the past several decades,
considerative effort has been directed at the polynucleotide level. Complete sequencing
of genome in a wide variety of simple organisms and great progress in the human
genome project provide the chance for the development of research at the protein level.
The expected proteins in human may be as many as millions if splice variants and post
translation modifications are considered (Wilkins et al., 1996; Binz et al., 1999; Wilkins
et al., 1999). Based on genome and protein databases such as SwissProt and NCBI
thousands of proteins are predicted. The complete set of proteins that result from a
genome is called the proteome (Wasinger et al., 1995), which is dynamic and highly
dependent on the type of cell and its state. The development of Mass Spectrometry tools,
such as the Matrix Assisted Laser Desorption Ionization (MALDI) and electrospray
ionization, provides effective tools to investigate protein levels in cell. Proteomics is a
method to display and detect all cellular proteins, and study multiple gene/protein
functions and networks (Schilling et al., 1999).
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1.7.1 Two Dimensional Gel Proteomics
In current proteomic studies, protein separation before identification is critical.
The separation of a complicated protein mixture from cells was firstly achieved more
than 30 years ago using two dimensional polyacrylamide gel electrophoresis (2D PAGE)
(O'Farrell, 1975). In this method, proteins are separated by their isoelectric point in one
dimension and molecular weight in the second dimension. In the first dimension, proteins
are loaded onto immobilized pH gradient strips, and separated under high voltage from
hundreds to thousands volts. The secondary dimension is similar to running a 1D gel. The
proteins in the 2D page are visualized by Coomassie blue staining, silver staining, or by
Sypro ruby staining and imaged by fluorescence scanning. Protein spots of interest are
cut out, and proteolytically digested to release peptides. Peptides from in-gel digestion
are loaded onto matrix for MALDI MS and the peptide can be sequenced by mass
spectrum fingerprint and then identified based on comparision to a database. It is
predicted that up to 5000 proteins can be displayed by this method, and post-translational
modifications and single-site mutations can be detected with proteins differing in
concentration by ratio of 10-4 to 10-5 detected.
Two dimensional PAGE proteomics has allowed many proteins in different
organisms or animal and human tissues to be mapped, but this method is labor intensive
and difficult to match protein spots on various gels. In addition, less abundant proteins,
proteins with low or high molecular weight as well as proteins with acidic or basic side
chains are difficult to detect. Additionally, membrane protein analysis is also difficult
using this method (Godovac-Zimmermann and Brown, 2001).
1.7.2 Isotope-coded Affinity Tag Proteomics
To overcome problems associated with 2D PAGE, Isotope-coded Affinity Tag
(ICAT) was developed by Gygi et al., and uses heavy and light reagents to label control
and treatment samples separately (Gygi et al., 1999). This gel free method allows more
automatic protein analysis. In this method, cysteine residues in amino acids are labeled
by a tag, which contains a biotin moiety for subsequent isolation of the labeled peptides.
Rather than displaying the cellular proteins by 2D PAGE, the cellular protein mixtures
are subjected to tryptic digestion after labeling, and the Cys-containing peptides isolated
by chromatography on an avidin column. Purified Cys-containing labeledpeptides are
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separated by 2D microcapillary liquid chromatography and ionized by electrospray
ionization, and identified by 2D LC-MS/MS. The ICAT proteomics method requires
much less sample for analysis compared with 2D PAGE, which is useful for studies of
subcellular organelle or where limited material is available. The heavy and light labeling
reagents differ in mass since they have different isotopes, and this mass difference help
MS determine if the peptide is from control or treatment sample. So far, ICAT reagents
have been labeled with deuterium or

13

C, and the mass difference between heavy and

light can be 8 or 9 Da (Lovell et al., 2005). The peptides are sequenced by mass
spectrometry and used for database searches to identify proteins based on their peptides.
1.8 The Effort to Find Efficient Treatment for TBI
Currently, research on TBI is directed at understanding the mechanisms of neuron
injury and the search to find an effective therapy for clinical application. Based on the
understanding of the injury, some treatment methods such as hypothermia (Davies, 2005)
and many kinds of drugs have been proposed. Current drugs under investigation include:
inhibitors or regulators targeting specific proteins such as lithium (Wada et al., 2005),
magnesium (Enomoto et al., 2005; Ghabriel et al., 2006), N-(4-fluorophenylsulfonyl)-Lvalyl-L-Lleucinal (Inoue et al., 2003), cyclosporine A (Rabchevsky et al., 2001),
progesterone (Fiskum G, 2006, p235), dexanabinol, and dexamethasone; antioxidants
such as metalloporphyrin (Tauskela et al., 2006), bromocriptine (Kline et al., 2004) and
N-acetylcysteine (Yi et al., 2006), and protective drugs with unknown mechanisms such
as methylprednisolone (Rabchevsky et al., 2002).
Creatine has been shown to increase lean body mass, muscular strength, and
sprint power, and is one potentially protective compound of interest in TBI (Matthews et
al., 1999; Sullivan et al., 2000). Creatine is an endogenous substance synthesized mostly
in kidney and liver. Creatine biosynthesis has two sequential steps catalyzed by Larginine:glycineamidinotransferase

and

S-adenosylmethionine:guanidinoacetate

N-

methyltransferase (Braissant et al., 2005). Cells with high energy demand can take up
creatine from the blood stream with the involvement of a specific creatine transporter
(CRT). Imported creatine can be converted to phosphocreatine by creatine kinase with
consumption of ATP provided through oxidative phosphorylation and glycolysis at
contact sites of mitochondria or in cytosol (Jacobus, 1985) (Figure 1.10).
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Phosphocreatine is an energy pool and can be available in cytosol. ATP levels in cytosol
can be maintained at a stable level with the hydrolysis of phosphocreatine to regenerate
ATP to satisfy the demand of different biological process, such as ATPase and other
ATP-regulated process, which contribute to the protective function of creatine. It was
shown that creatine can regulate the mitochondrial transition pore by stimulating creatine
kinase located in the intermembrane space of mitochondria (O'Gorman et al., 1997).
Creatine supplemented animals maintained better calcium buffering capacity compared to
animals without suppleentation following brain injury (Sullivan et al., 2000). Studies also
show that creatine can function as an antioxidant in vitro, showing a significant ability to
remove superoxide and peroxynitrite (Lawler et al., 2002).
Oral supplementation of creatine (Cr) has recently been shown to be protective in
a variety of neurodegenerative diseases, including HD, PD, ALS, and TBI (Klivenyi et
al., 1999; Matthews et al., 1999; Ferrante et al., 2000; Sullivan et al., 2000). In animal
models of ischemia, creatine supplementation resulted in neuroprotection and a
remarkable reduction in ischemic brain infarction. Caspase-3 activation and cytochrome c
release were significantly reduced, and ATP levels were maintained (Zhu et al., 2004).
Despite its well documented neuroprotective properties and its possible mechanism,
creatine’s protective role in TBI is not well understood.
1.9 Experiment Design
Because secondary injury is the only possible curable damage so far in TBI we
decide to investigate the factors in secondary injury to find a clue for clinical therapy. As
mentioned ealier in the desertation that oxidative damage and mitochondrial dysfunction
play key roles in TBI. In order to understand the effect of age on TBI, this dissertation
was to investigate the oxidative damage in TBI in aging, and to elucidate the exacerbated
injury in TBI in aging. In our study, young (3 months), middle aged (12 months) and
aged (22 months) animals were investigated using a controlled cortical impact injury. To
evaluate mitochondrial dysfunction, mitochondria were isolated following TBI and
subjected to proteomics. To test potential therapeutics to prevent against secondary
injury, oxidative damage in creatine supplemented animals was measured.
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1.9.1 Oxidative Stress in TBI in Aging
As mentioned earlier, aging is an important factor in brain injury, and aged
patients are more likely to sustain more severe injury than young adult patients. The
reason for this phenomenon is not well understood. Previous studies show oxidative
stress could be a factor for many pathological processes, but has not been investigated in
head trauma in aging. In the current project, Fisher-344 rats were subjected to CCI, and
HNE and acrolein, toxic markers of lipid peroxidation, evaluated using immunochemistry
(dot-blot) at 1 and 7 days post injury. Further studies were performed to determine
antioxidant defense capacities of animals in head trauma in aging. The antioxidant
enzyme activities, including MnSOD, Cu/ZnSOD, GPx, GSSG-R, and GST, were
investigated.
DNA oxidation may contribute to gene mutation or protein expression changes,
and is widely used as a marker for oxidative damage. To determine if the oxidative stress
in TBI in aging impacts DNA, 8-OHG, FG, 8-OHA, FA, and 5-OHC were investigated in
injured rat brains using GC/MS-SIM. Stable isotope labeled oxidized DNA bases labeled
with 15N and 13C were used as internal standards for quantification.
1.9.2 Protection by Creatine in TBI
Creatine has been shown to be neuroprotective in neurodegenerative
disorders. In order to investigate the effect of creatine on TBI, Sprague-Dawley rats with
1% and 2% creatine supplementation were subjected to CCI, sacrificed at 24 h post
injury, and HNE and acrolein levels in cortex and hippocampus measured using dot-blot
immunochemistry. Additionally, enzyme activities, including MnSOD, Cu/ZnSOD, GPx,
GSSG-R, and GST, were investigated.
1.9.3 Mitochondrial Proteomics
Previous studies showed oxidative damage, ion homeostasis disruption, and ATP
depletion following TBI. Mitochondria play a key role in these pathologies and regulate
the fate of neurons in TBI. Mitochondrial dysfunction is also the reason of aging.
Although studies showed that mitochondrial swelling, mitochondrial membrane
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permeability changes, reduced amount of isolated mitochondria, respiration chain
damage in TBI, the individual mitochondrial protein expression level is not evaluated. In
this dissertation, young Fisher-344 rats were subjected to CCI and the mitochondria were
isolated at 1 and 24 h post injury. Mitochondrial protein expression was quantified using
isotope-coded affinity tag (ICAT) labeling and 2D-LC/MS/MS. In the further, we will
use middle aged and aged animals to evaluate mitochondrial dysfunction in TBI in aging.

Copyright © Changxing Shao 2007
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Chapter Two
Materials and methods
2.1 Materials
Stable isotope labeled oxidized bases were obtained from Cambridge Isotope
laboratories (Andover, MA, USA), and included 8-[8-13C,7,9-15N2] hydroxyguanine,
[formyl-13C, diamino-15N2] fapyguanine, 8-[8-13C,6,9-diamino-15N2] hydroxyadenine,
[formyl-13C, iamino-15N2] fapyadenine, and 5-[2-13C,1,3-15N2] hydroxycytosine. Other
chemicals are purchased from Sigma (St Louis, MO, USA) if not specified.
2.2 Animal Surgical Procedures
The present studies were conducted in adult male Fisher 344 rats or SpragueDawley rats. All injury procedures were performed under isofluorane anesthesia and were
approved by the Animal Care and Use Committee of the University of Kentucky. Every
effort was made to minimize both the possible suffering and number of animals used. All
animals were housed 2/cage on a 12 hour light/dark cycle with free access to water and
food. 51 Young (3 mo), 30 Middle-aged (12 mo) and 27 Aged (22 mo) Fisher-344 rats
(205-500 g/animal) were subjected to a unilateral cortical impact on the surface of the
brain utilizing an electronic controlled pneumatic impact device (ECPI) previously
described (Baldwin and Scheff, 1996) and performed by Dr. Stephen Scheffs laboratory.
Briefly, each animal was anesthetized with 2% isofluorane and placed in a Kopf
stereotaxic frame with the incisor bar set at -5. Following a midline incision and
retraction of the skin, a 6 mm diameter craniotomy was made approximately midway
between bregma and lambda with a Michele hand trephine (Miltex, NY). The skull disk
was removed without disturbing the dura. The exposed brain was injured using the ECPI.
The impactor rod had a beveled tip with a 5 mm diameter that was used to compress the
cortex to a depth of 1.3 mm at 3.5m/sec. Following injury, Surgicel (Johnson & Johnson,
TX) was placed over the injury site, the skull disk replaced, and sealed with a thin layer
of dental acrylic. The incision was closed with surgical staples and animals maintained at
35 °C--37 °C with a heating pad. Eighteen young (3 month), 6 middle aged (12 month),
and 6 aged Fisher-344 rats were subjected to sham surgery following the same procedure
except brains were not impacted. For the creatine study, Sprague-Dawley rats were used.

34

The animals were fed a 1% (N = 8) or 2% (N = 8) creatine diet 2 weeks before surgery.
Control animals (N = 8) were fed a regular diet. Animals on the creatine or regular diet
were subjected to ECPI following the procedure described above.
2.3 Tissue Collection
Animals were anesthetized using 2% isofluorane and subjected to decapitation
and the brains removed. For studies of HNE and acrolein in TBI in aging, twenty-one
young, twenty-four middle aged, and twenty-one aged Fisher-344 rats were used. Ten
young, ten middle-aged, and eight aged animals were allowed to survive for 24 h. Eleven
young, fourteen middle-aged, and thirteen aged animals were euthanized 7 days post
injury. To study the effects of TBI and aging on DNA oxidation, young (N = 6), middleaged (N = 6), and aged (N = 6) Fisher-344 rats were subjected to injury, an additional 6
middle-aged, 6 aged animals were subjected to sham surgery. Injured and sham animals
were euthanized 24 h post injury. For mitochondrial proteomics studies, 12 injured young
Fisher-344 rats were sacrificed 1 hr post injury, 12 injured and 12 sham young animals
sacrificed 24 hr post injury. All animals used in these studies were dissected on ice
following decapitation. Ipsilateral (IP) and contralateral (CON) cortex and hippocampus
were obtained and then frozen immediately in liquid nitrogen. In addition, four naive rats
were anesthetized using isofluorane and brains were extracted as described for injured
animals. An additional four naive animals were anesthetized using isofluorane and brains
flash-frozen in skull using liquid nitrogen following a midline incision. The animals were
stored at -80°C, and cortex and hippocampus were extracted the next day.
For creatine studies, 24 young (3 month) Sprague-Dawley rats were provided a
creatine supplementation or regular diet for 2 weeks and were sacrificed at one day after
injury. IP cortex and hippocampus and CON cortex and hippocampus were dissected as
described above. All the tissue samples were stored at -80°C until used for analysis.
2.4 Method for Estimating Tissue Sparing
In order to examine tissue sparing/loss in TBI in aging, 6 young, 6 middle-aged
and 5 aged animals were subjected to injury, overdosed with sodium pentobarbital and
transcardially perfused with 0.1 M phosphate-buffered saline (PBS, pH 7.4) followed by
4% paraformaldehyde in PBS, and decapitated. Whole brains were removed, postfixed in
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4% paraformaldehyde containing 10% sucrose at 4°C overnight and subsequently
cryoprotected in a 20% sucrose/4% paraformaldehyde solution for 24 hrs. Coronal 50 μm
sections were cut with a cryostat throughout the rostral-caudal extent of the injured cortex
extending from the septal area to the posterior aspect of the hippocampus. Sections were
stained with cresyl violet and subjected to image analysis (NIH Image v. 1.62).
Quantitative assessment of spared tissue employed the Cavalieri method as previously
described (Michel and Cruz-Orive, 1988; Sullivan et al., 1999). The amount of tissue
sparing was expressed as percentage of the total cortical volume of injured hemisphere
compared to the contralateral uninjured hemisphere. In this way each animal is used as its
own control. These methods obviate a need to adjust values due to possible differential
shrinkage resulting from fixation and tissue processing. A total of twelve evenly spaced
sections were used for each animal. All sections were assessed blind with respect to age
group.
2.5 Tissue Processing for Enzyme Activity and Oxidative Stress Assays
Tissue samples (cortex, peumbra, and hippocampus) for enzyme and lipid
peroxidation assays were homogenized using a chilled Teflon Dounce homogenizer on
ice in 1 mL HEPES buffer (pH 7.4), containing 137 mM NaCl, 4.6 mM KCl, 1.1 mM
KH2PO4, 0.6 mM MgSO4, pepstatin A (1 µM), leupeptin (1.2 µM), aprotinin (0.1 µM)
and PMSF (0.23 mM). Samples were centrifuged at 100,000 × g for one hour at 4 °C for
1 hour and the supernatant were kept for analyses.
2.6 Protein Assay
Total protein concentrations were determined using the Pierce BCA method
(Sigma, St. Louis, MO). In detail, a UV-Vis spectrometer (Labsystem Multiscan
MCC/340) was programmed using protein standards with concentrations of 0, 1, 5, 10,
15, and 20 μg/μl. For the protein assay, standards were loaded in duplicate sequentially in
the “A” row of 96-well plate, and protein samples were loaded in duplicate in other wells
of the same plate. After adding 100 μL BCA reagent (bicinchoninic acid, containing 1%
Cu2+), the volume in each well was 200 μL, and the plate was incubated at 37 °C for 20
min. The Cu2+ was reduced to Cu+, which coordinates with bicinchoninate to form a
complex with purple color that absorbs at 562 nm. The plate was read at wavelength of
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562 nm using a multiwell plate reader and the data were converted to protein
concentration in the well based on calibration curve from known protein standards.
2.7 Method of Nuclear DNA Isolation
The method of Mecocci et al. (Mecocci et al., 1993) with modification (Wang et
al., 2005) was used to isolate nuclear DNA. Briefly, brain samples were homogenized on
ice using a Teflon-coated Dounce homogenizer in MSB-Ca2+ buffer (pH 7.5), containing
0.21 M mannitol, 0.07 M sucrose, 0.05 M Tris-HCl, 3 mM CaCl2. Na2EDTA was added
to the homogenate with a final concentration of 0.01 M. The homogenate was centrifuged
at 600 × g and 4 °C for 5 min, and nuclear pellets collected, rinsed in MSB-Ca2+ and
repelleted. The pellets were suspended in 700 µl digestion buffer ( 0.5% sodium dodecyl
sulfate, 0.05 M Tris-HCl, 0.1 M Na2EDTA) with proteinase K (0.5 mg/ml) in a 55 °C
water-bath overnight. After digestion, 30 µl 5 M NaCl solution was added, and solution
extracted 3 times with phenol (containing 5.5 mM 8-hydroxyquinoline) and chloroform
(containing 4% isoamyl) to remove proteins from the digestion mixture. 8Hydroxyquinoline was used to avoid artificial oxidation as previously described (Wang et
al., 2005). Following extraction, the upper aqueous layer was collected and 20 µl NaCl (5
M) and two volumes of cold absolute ethanol added, and the DNA precipitated.
Following centrifugation, the DNA was collected, washed three times using 60% ethanol,
and dried.

The isolated DNA was dissolved in autoclaved water, and purity and

concentration measured at 260 nm and 280 nm using a Genesys 10 UV/Vis spectrometer
(Rochester, NY, USA).
2.8 Isolation of Mitochondria
A modification of the procedure by Mecocci et al (1993) was used to isolate
mitochondria (Mecocci et al., 1993). The cortices or hippocampi from three animals were
used to make a pooled sample. Brain samples were homogenized on ice using a Tefloncoated Dounce homogenizer in MSB-Ca2+ buffer. The homogenate was centrifuged at
600 × g for 5 min at 4 °C (Beckman Avanti J25 centrifuge), and the supernatant
collected. The supernatant was then centrifuged at 20,000 × g for 20 min, and a
mitochondrial enriched fraction obtained. The raw mitochondria were suspended
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in 2 mL MSB-Ca2+ buffer, loaded on the top of Percoll/ MSB-Ca2+ gradient (1:1) in a 10
mL centrifuge tube, and centrifuged at 50,000 × g for 1 h (Beckman optima L-90K
ultracentrifuge). Several bands were observed after centrifugation and the light brown
band (ρ = 1.035) was collected. This fraction was centrifuged at 10,000 × g at 4 °C to
obtain enriched mitochondria. The mitochondrial pellets were washed twice using MSBCa2+ buffer. The pellets were homogenized in micro Douncer homogenizers on ice using
distilled water, and the protein concentration measured using the Pierce BCA method.
Four samples (75 μg) for each group were pooled, and aliquoted to 100 μg samples for
proteomics.
2.9 4-Hydroxynonenal and Acrolein Assay
Dot-blot analyses of HNE and acrolein modified proteins were carried out using a
Schleicher & Schuell Dot-blot apparatus, and the method described by Saiki et al. with
modification (Saiki et al., 1986). Briefly, 20 μg of 100,000 × g supernatant protein were
loaded in triplicate onto nitrocellulose membrane in a 40-50 μL volume. Vacuum was
applied until the solution was evacuated from the wells. After air drying, blots were
incubated overnight in 5% dry milk in 0.05% Tween-20/tris buffered saline (TTBS, 0.1
M Tris-HCl, 0.155M NaCl, pH = 7.5) to block nonspecific binding of the primary
antibody. Blots were probed with a 1:2000 dilution of anti-HNE (Alpha Diagnostic, San
Antonio, TX) or anti-acrolein (United States Biological, Swampscott, MA) polyclonal
antibodies for 1 h at room temperature, washed in TTBS 3 × 10 minutes and then
incubated with a 1:3000 dilution of horseradish peroxidase-conjugated goat anti-rabbit
antibody for 1 h.

Detection of bound antibodies was achieved by enhanced

chemiluminescence (Amersham ECLTM western blotting detection reagents, Amersham
Pharmacia Biotech, Piscataway, NJ) and exposure of membrane to Hyperfilm (Film
developer, Kodak, 2000). Blots were scanned and measured using Scion Image (NIH).
The average density of the triplicate dots was calculated for HNE or acrolein content in
an individual sample.
To validate linearity of response of the dot-blots, aliquots of 100,000 × g protein
from a representative rat were incubated for 4 h at 37 °C with increasing concentration of
HNE (10, 25, 50 100 μM) or acrolein (1.0, 5.0, 10, 25 μM). The acrolein and HNE spiked
sample were subjected to dot-blot analyses as described above.
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2.10 Enzyme Acyivity Assays
The enzyme activity could reflect the antioxidant capacity of cell, and shows the
antioxidant response of cells following injury. In this dissertation, MnSOD, Cu/ZnSOD,
GPx, GSSG-R, and GST activities were quantified using UV/Vis spectrometry.
2.10.1 Superoxide Dismutase
The method for assay of total SOD (Cu/Zn- and MnSOD) activity was that of
Misra and Fridovich (Misra and Fridovich, 1972) as modified by Mizuno (Mizuno,
1984). Briefly, 70-µl aliquots of the 100,000 × g supernatant were placed in UV-grade
cuvettes and 1.46 mL 68mM NaH2PO4 containing 1.35 mM EDTA (pH 7.8), 100 µL 4
mM xanthine, 170 µL 3.53 mM epinephrine (pH 11.5) added. Following incubation at 30
ºC for 5 minutes, 10 µL xanthine oxidase was added to the solution and the absorbance
followed at 320 nm (Genesys 10 UV, Rochester, NY, USA) for 3 minutes. The blank for
the assay contained 70 µL supernatant boiled in water for 5 minutes. For MnSOD, the
same protocol was followed with the addition of 200 µL 20 mM KCN. Enzyme activities
were expressed as units per microgram protein, where 1 unit reduces the absorbance
change by 50%. Cu/Zn activity was obtained by subtracting MnSOD activity from total
activity. Activities are expressed as mean ± SD percent of control.
2.10.2 Glutathione Transferase
GST activity was assayed using the method of Ricci et al, which measures the rate
of conjugation of 7-chloro-4-nitrobenzo-2-oxa-1, 3-diazole (NBD-Cl) with glutathione
catalyzed by glutathione transferase (Ricci et al., 1994). The NBD-Cl complex is a stable,
yellow compound that strongly absorbs at 419 nm with a molar absorption coefficient of
14.5 mM-1cm-1. For the assay, 1.6 mL of 0.1 M sodium acetate buffer (pH 5.0) was mixed
with 200 µL 0.2 mM NBD-Cl and 100 µl 0.5 mM reduced glutathione. The reaction was
initiated by addition of 100 µL aliquots of the 100,000 × g tissue supernatant. The
absorbance was followed for 3 minutes. Enzyme activity was expressed in units/μg total
protein, with 1 unit = 1 nmol

NBD-Cl complex formed per minute. Results are

expressed as mean ± SD percentage of control activity.
2.10.3 Glutathione Peroxidase
For GPx activity, the method of Paglia and Valentine (Paglia and Valentine,
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1967) as modified by Mizuno (Mizuno, 1984) was followed, which measures the rate of
oxidation of reduced glutathione to oxidized glutathione by H2O2 as catalyzed by GSHPx present in the tissue supernatant. For the assay, 100 µL aliquots of the 100,000 × g
supernatant were added to 1.68 mL 68 mM KH2PO4 buffer (pH 7.0) containing 1mM
EDTA, 100 µL 2 mM NADPH, 10 µL 66 U/mL GSSG reductase, 10 µL 200 mM
sodium azide. The assay was initiated with 100 µL 15 mM H2O2. The decrease in
absorbance was followed for 2 minutes at 340 nm. Quantification was based on a molar
absorption coefficient of 6,270 M-1 cm-1 for NADPH (Braughler et al., 1986). The blank
in the enzyme assay consisted of 100 µL supernatant heated at 100 ºC for 5 minutes, and
its value was subtracted from the sample value to correct for nonenzymatic oxidation of
glutathione. Activity of the enzyme was expressed in units/μg total protein, with 1 unit =
1 nmol NADPH oxidized per minute, and final data for the activity in ipsilateral tissue
was expressed as mean ± SD percent of control activity.
2.10.4 Glutathione Reductase Assay
The method of assay for GSSG-R is from Mizuno (Mizuno, 1984) and is based on
the reduction of oxidized glutathione by GSSG-R and exogenous NADPH. The assay
measures a loss in absorbance at 340 nm as NADPH is converted to NADP+. Onehundred-microliter aliquots of the 100,000 × g supernatant were added to 1.58 mL 68
mM KH2PO4 buffer containing 1 mM EDTA with 100 μL 2 mM NADPH. The
absorbance was followed at 340 nm for 3 minutes following initiation of the reaction
initiation by addition of 220 μL 13.6 mM oxidized glutathione. Enzyme activities were
calculated as described for GPx and expressed as mean ± SD percent of control activity.
2.11 DNA Hydrolysis and Derivatization
For GC/MS-SIM, 20 µg DNA was aliquoted into glass vials to which internal
standards (1 μg for each) were added, and the samples freeze-dried overnight under
vacuum. Acid hydrolysis was performed by heating the DNA and standards in 250 µl
90% formic acid in evacuated and sealed conical glass tubes for 30 min at 140 °C. After
lyophilization, 200 µl derivatization reagent (pyridine:BSTFA 1:1 (vol/vol)) added, the
tube evacuated, and derivatization carried out at room temperature for 2 h. The
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derivatized samples (Figure 2.1) were freeze-dried, and 20 µl BSTFA added immediately
before GC/MS injection.
2.12 GC/MS-SIM
Derivatized DNA samples/standards were analyzed on a Hewlett-Packard 5972A
mass selective detector interfaced with a Hewlett-Packard 6890 gas chromatograph and
equipped with a computer workstation. The injection port and the GC/MS interface were
kept at 250 °C. Separation was performed on a fused-silica capillary column (30 m ×
0.25mm i.d.) coated with cross-linked 5% phenylmethylsiloxane (film thickness 0.25 µm,
HP-5MS). Ultra pure helium was used as carrier gas with a constant flow rate of 1.1
ml/min. Derivatized samples (2 µl) were injected directly into the GC injection port
using the splitless mode. The initial temperature was held for 2 min after sample
injection, and the oven temperature was programmed through the following four ramps:
ramp 1, column temperature was increased from 100 °C to 178 °C at a rate of 3 °C /min;
ramp 2, temperature was increased from 178 °C to 181 °C at rate 0.3 °C /min; ramp 3,
column temperature was raised at a rate of 3 °C /min from 181 °C to 208 °C; ramp 4, rate
was 10 °C /min from 208 °C to 280 °C. The final temperature was maintained for 2 min.
The total run time was 56.2 min for each sample and the temperature of the mass
spectrometer ion source was maintained at 180 °C. Mass spectra were recorded from 9 to
56.2 min. The five bases of interest were well separated at following retention times: 5hydroxycytosine
(22.0 min), fapyadenine (28.0 min), 8-hydroxyadenine (32.5 min), fapyguanine (39.8
min) and 8-hydroxyguanine (46.0 min) (Figure 2.2).
2.13 Isotope-coded Affinity Tag (ICAT) Labeling Mitochondrial Protein for MS
Analysis
In the current study, 100 μg mitochondrial proteins from sham animals and
injured animals were labeled with light (C10H17N3O3) and heavy (13C9CH17N3O3) ICAT
reagents (ICAT kit, Applied Biosystems, Foster City, CA), respectively as following
manufacturer’s instructions (Figure 2.3).

Briefly, mitochondrial protein from sham

animals and the same amount of protein from injured animals were aliquoted, denatured
by adding 80 µL denaturing buffer and 2 µL reducing reagent, and heated in a boiling
water bath for 10 min. For labeling, proteins from injured animals were mixed with
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5-OHcytosine

8-OHFapyadenine adenine
Fapyguanine

Figure 2.2.Representative chromatogram of DNA oxidized adducts.
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Figure 2.3. Scheme of ICAT labeling.
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Analyze by 2D-LC/MS/MS
Protein identification and quantification.

heavy ICAT reagent, and proteins from control mixed with light ICAT reagent. The
labeling was performed in water bath at 37 °C for 2 hours. During labeling, proteins
containing cysteine residues react with iodoacetamine group of the ICAT reagent.
Proteins from control and injured animals were then combined and digested 16 h at 37 °C
by using sequencing grade modified trypsin (Promega, Madison, WI). Excess ICAT
reagents, Tris(2-carboxyethyl)phosphine (TCEP) and SDS in sample mixtures were
removed using cation exchange. Resulting peptides were added to avidin column that
isolated ICAT labeled peptides. The isolated labeled peptides were lyophilized,
resuspended in trifluoroacetic acid (TFA) and incubated in a water bath 2 hours at 37 °C
to cleave the biotin portion of the ICAT tags. Peptides were dried in a speed vacuum
centrifuge and reconstituted in 10 µL 5% ACN/95% aqueous formatic acid (0.1%) and
extracted again using C18 zip-tips prior to 2-D-LC/MS/MS.
2.14 Analysis of ICAT-labeled Peptide Samples Using 2D-HPLC and Mass
Spectrometry
In this study, ICAT lebeled samples were analyzed using 2D-LC/MS/MS
(ThermoFinnigan Deca quadruple ion trap mass spectrometer), and peptides were
separated using 2-D LC (Peng and Gygi, 2001; Wolters et al., 2001). 2D LC-MS/MS was
carried out using a column composed of strong cation exchange (SCX) and reverse phase
C18 resins and performed by Dr. Lynn in his lab. The peptides were separated based on
charge using SCX, and further separated on C18 residue based on hydrophobicity. An
ammonium acetate gradient from 0 to 250 mM was used for peptide separation in SCX.
Thirteen individual chromatographic profiles were obtained for each sample, indicating
13 fractions separated by SCX. Each fraction from SCX separation was subjected to
further separation using an acetonitrile gradient from 5% ACN/95% aqueous formic acid
(0.1%) to 70% ACN/aqueous 30% formic acid (0.1%) over 80 min (Figure 2.4). Peptides
in the column effluent were directly subjected to electrospray ionization, and introduced
into a Finnigan LCQ Deca ion trap mass spectrometer for mass analysis. Mass spectra of
peptides were saved for later data base searches.
2.15 Protein Identification
In order to identify proteins, acquired tandem mass spectra of peptides were
subjected to protein database searches using TurboSEQUEST (ThermoFinnigan). First
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Figure 2.4. Representative chromatogram and MS spectrum of ICAT labeled
peptides.
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2000

of all, modifications were made to the protein database and the search parameters of
TurboSEQUEST. Briefly, a sub-database of the Uniprot SwissProt non-redundant
rat/mouse protein database was set up using the Fasta Database Utilities of Bioworks.
This sub-database was specified to have only tryptic, cysteine-containing peptides. In
addition, search parameters of TurboSEQUEST were edited to expect static
modifications of cysteine residues that corresponded to 227.1273 u which is the mass of
the light ICAT label or 236.16 u, the mass of expected heavy ICAT modifications.
TurboSEQUEST results were filtered by cross-correlation score (Xcorr) criteria, Xcorr >
1.8 for +1 peptides, >2.3 for +2 peptides, and >3.0 for +3 peptides. Proteins identified in
database search were scored and the protein with best score was considered the hit in the
data base search. Relative ratios of heavy/light (injured/sham) peptides were obtained
using the XPRESS program of Bioworks 3.1 (Figure 2.5). ICAT ratios for all tryptic
peptides identified from a protein were averaged to obtain the relative ratio of that
protein.
2.16 Western Blot
To verify the purity of mitochondria isolated using our extraction protocol,
mitochondrial proteins, cytosolic protein samples and nuclear specimens were subjected
to SDS-PAGE on a 4-20% gradient gel (Bio-Rad) and transferred to nitrocellulose
membrane for Western blot analysis. The blots were incubated 1 h in 5% dry milk in
0.05% Tween-20/Tris buffered saline (TTBS) to block nonspecific binding of the primary
antibodies. Blots were incubated with a 1:3000 dilution of anti-VDAC (Calbiochem,
1:3000), anti-Lamin B (1:1000) or anti-MAP-2 (1: 1000) primary antibody for 1 h at
room temperature, washed in TTBS 3 × 10 min and then incubated with a 1:3000 dilution
of horseradish peroxidase-conjugated goat anti-rabbit for 1 h.

Detection of bound

antibodies was achieved by enhanced chemiluminescence (Amerisham Pharmacia
Biotech) and exposure of the membrane to Hyperfilm (Amerisham) (Figure 2.6).
To verify proteomics data, equal amounts of mitochondrial protein (20 µg) from 3
independent samples from IP or CON cortex at each time point were subjected to
Western blot and probed using anti-VDAC (Calbiochem, 1:3000) or anti-hexokinase 1
(Chemicon, 1:3000) antibodies. Staining intensity was quantified using Scion Image
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Figure 2.5. Representative chromatogram showing the heavy and light ICAT labeled
peptide
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Figure 2.6. Representative Western blots of mitochondrial, cytosolic, and nuclear protein
specimens to evaluate purity of fractions. VDAC is a mitochondrial protein marker,
Lamin B is a nuclear envelope protein, and MAP-2 is cytosolic protein. Results of the
analyses show no cross contamination of fractions.
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(NIH). The average band densities from three samples of IP or CON cortex at a time
point indicates the protein content in the tissue at that time point.
2.17 Statistical Analyses
A two-tailed Student t test was used for time course differences in lipid
peroxidation and enzyme activities. A two-tailed Student Paired t test was used for IP and
CON differences in lipid peroxidation, DNA oxidation, and antioxidant enzyme
activities. Age dependent differences in enzyme activities, lipid peroxidation, DNA
oxidation, and percent tissue sparing of the injured cortex were compared using one-way
ANOVA and the student-Newman-Keuls post hoc test for age dependent differences
using the commercially available ABSTAT software. Significance was established as p <
0.05. One-way ANOVA and student-Newman-Keuls post hoc test was also used for
enzyme and lipid peroxidation measures in the creatine study. For ICAT proteomics data,
one-sample t tests were used to calculate the p values for the rejection of the null
hypothesis that the mean ratio of the peak areas is 1.0 (signifying no difference in the
protein levels between injured animals and sham). Correction for multiple comparisons
was done according to the Bonferroni procedure.

Copyright © Changxing Shao 2007
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Chapter Three
Experimental Results
3.1. Oxidative Damage and Antioxidant Enzyme Activities in TBI in Aging
Oxidative damage is shown to play a key role in neurodegeneration following
TBI. In order to quantify oxidative damage in aging, markers of oxidative damage, 4HNE, acrolein, 8-OHG, FG, 8-OHA, FA, and 5-OHC, were quantified in cortex and
hippocampus following TBI. To evaluate antioxidant defense capacity, MnSOD,
Cu/ZnSOD, GPx, GSSG-R, and GST activities were measured.
3.1.1 Assessment of Tissue Sparing in TBI in Aging
At 7 days post injury, 6 young, 6 middle-aged and 5 aged rats were assessed for
cortical tissue sparing immediately below the site of impact (Figure 3.1). Analysis of
variance showed a statistically significant difference among group means [F(2,14) =
17.36, p< 0.001]. Post-hoc analysis showed significant differences (p < 0.05) between
young and middle aged, and young and aged groups. Young animals showed 89.4 ± 4.4%
(SD) tissue sparing with middle aged and aged animals showing 77.1 ± 3.9% (SD) and
77.0 ± 3.8% (SD), respectively (p <0.05) (Figure 3.2). There were no significant
differences in tissue sparing between middle aged and aged animals.
3.1.2 HNE and Acrolein Dot Blot Calibration
To validate antibody response for the dot blot assays, representative protein
samples were incubated with HNE or acrolein and subjected to dot blot analysis. Figure
3.3 shows a statistically significant linear response with increasing HNE levels (r = 0.95,
p < 0.0001 ). Figure 4.4 shows similar results for acrolein (r = 0.84, p = 0.0006 ).
3.1.3 Comparison of HNE and Acrolein in Sham, and Naive Animals with and
without Flash-freezing Prior to Cervical Dislocation and Tissue Extraction
In order to determine if artifactual ROS are produced during post mortem tissue
extraction, HNE and acrolein levels of naive animals with and without insito flashfreezing before tissue extraction were evaluated. Our results show no significant
differences in HNE or acrolein levels between the animals subjected to different tissue
extraction methods (Figure. 3.5). Comparison of HNE and acrolein levels in CON cortex
and hippocampus of injured animals to levels in CON and IP tissues of sham,
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Figure 3.1. Representative rat brain and coronal section at 7 days post injury.
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Figure 3.2. Percentage of tissue sparing in Fisher-344 rats subjected to 1.5 mm injury.
ANOVA showed a significant difference between the three age groups. Bars represent
the mean ± SD. Student-Newman-Keuls, *p < 0.05.
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Figure 3.3. Correlation of HNE immunohistochemistry staining of protein samples
incubated with increasing concentrations of HNE. Each sample was loaded in triplicate.
Calibration curve of HNE concentration vs immunohistochemical staining, r = 0.9532
(bottom). Representative dot-blot with increasing HNE concentrations (top).
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Figure 3.4. Correlation of acrolein immunohistochemical staining of protein samples
incubated with increasing concentrations of acrolein. Each sample was loaded in
triplicate. Calibration curve of acrolein concentration vs immunohistochemical staining, r
= 0.8414 (bottom). Representative dot-blot with increasing acrolein concentrations (top).
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HNE and acrolein levels in animals with and without flash-freezing
before tissue extraction

% of animals without flash-freezing
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Animals without flash frozen
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HNE
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Figure. 3.5. 4-Hydroxynonenal and acrolein levels in cortex and hippocampus of naïve
animals with and without flash-freezing before brain extraction. For flash-frozen animals,
the brains were frozen using liquid nitrogen following isofluorane anesthetization and
midline cranial incision. The frozen animals were stored at -80 °C, and the brain removed
the next day. Bars represent mean ± SD of animals without flash-freezing before cervical
dislocation.
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animals showed no significant differences (Figure. 3.6).
3.1.4 HNE and Acrolein Relative Content in Hippocampus Following TBI in Aging
To evaluate lipid peroxidation in IP and CON hippocampus 1 and 7 days post
injury, we measured levels of HNE and acrolein. Because the CCI injury model produces
a gradient of secondary injury with no significant changes of antioxidant response in
distal areas (DeKosky et al., 2004), we used CON tissue as internal controls to limit
animal variability, and focused on oxidative response in IP tissues. The data in IP tissues
are expressed as percentage of CON tissues and show HNE levels in IP hippocampus are
significantly (p < 0.01) increased 24 h post injury in young (230.1 ± 53.4%), middle aged
(253.2 ± 45.1%) and aged animals (288.6 ± 46.3%) (Figure 3.7). Statistical analyses
showed an age dependent difference [F(2,27) = 3.2334, p < 0.05], with aged animals
showing significantly higher HNE levels than young animals (p < 0.05) 24 h post injury.
Another lipid peroxidation marker, acrolein, showed a significant increase (p < 0.05) in
aged IP hippocampus compared with CON hippocampus. ANOVA showed a significant
age dependent increase 24 h post injury [F(2,27) = 3.5055, p < 0.05], although the
differences were more modest compared with HNE levels in aging (Figure. 3.7). At 7
days post injury, HNE levels remained elevated in an age dependent manner [F(2,19) =
9.598, p < 0.01]. HNE levels in IP hippocampus of aged animals were significantly
increased compared with aged CON hippocampus (Figure 3.8). For young (104.3 ±
10.3%) and middle aged (138.8 ± 55.6%) animals, the changes in HNE levels in IP
hippocampus were not statistically significant compared to CON tissues. No significant
changes were observed for acrolein in hippocampus 7 days post injury for any age group
(Figure 3.8).
3.1.5 HNE and Acrolein Relative Content in Cortex Following TBI in Aging
In cortex, mechanical injury triggers cell necrosis and apoptosis with concomitant
production of ROS and toxic byproducts of lipid peroxidation including HNE and
acrolein. In the current study, HNE and acrolein levels in IP and CON cortices were
measured,

and

expressed

as

percentage
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HNE and acrolein levels in injured and sham animals
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Figure. 3.6. 4-Hydroxynonenal and acrolein levels in CON tissues of injured animals and
CON and IP tissues of sham animals. Bars represent mean ± SD of CON tissues of
injured animals.
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HNE levels in hippocampus at 24 h post injury

Percent of CON hippocampus

400

CON hippocampus
IP hippocampus
300

*

*, $
*

200

100

0

Young

Middle-aged

Aged

Acrolein levels in hippocampus at 24 h post injury

Percent of CON hippocampus

200

CON hippocampus
IP hippocampus
150

*, $

100

50

0

Young

Middle-aged

Aged

Figure 3.7. HNE and acrolein levels in hippocampus at 24 h post injury. Bars represent
the mean ± SD. *p < 0.01 compared with CON hippocampus of the corresponding age, $p
< 0.05 compared with young animals IP hippocampus.
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Figure 3.8. HNE and acrolein levels in hippocampus at 7 day post injury. Bars represent
the mean ± SD. *p < 0.01 compared with CON hippocampus of the corresponding age, $p
< 0.05 compared with young animals IP hippocampus.

60

analysis of levels of HNE modified proteins in IP cortex in young, middle aged, and aged
animals 24 h post injury showed HNE levels in IP cortices were significantly (p < 0.01)
increased compared to CON tissues for each age. No age dependent changes were
observed among young, middle-aged, and aged animals (Table 3.1). Acrolein levels in IP
cortex did not change significantly in any age group compared with their CON cortices at
24 h post injury. At 7 days post injury, HNE levels increased significantly (p < 0.01) for
middle aged animals and showed a trend toward an elevation (p < 0.1) for aged animals
in cortex (Table 3.1). Post hoc testing following ANOVA showed HNE levels were
significantly higher in middle aged animals compared with young animals [F(2,17) =
87.037, p < 0.001]. Our data also showed significantly increased acrolein in middle aged
and aged animals compared with young animals 7 days post injury (Table 3.1).
3.1.6 DNA Oxidative Damage in TBI in Aging
Using the method of Mecocci et al. (1993) as modified in our laboratory (Wang et al.,
2005), we isolated nuclei with high purity. Using stable isotope labeled internal
standards, multiple oxidized DNA base adducts were quantified, providing a
comprehensive measure of DNA oxidation. Our data show an age dependent increase of
8-hydroxyguanine levels in IP cortex [F(11,66) = 6.76, p < 0.0001] and hippocampus
[F(11,67) = 5.93, p < 0.0001] of injured animals (Figure 3.9 and 3.10). 8-OHG levels in
IP cortex of aged injured animals were significantly (p < 0.05) increased compared to
young and middle aged animals. In addition, levels of 8-OHG in aged and middle aged IP
hippocampus were significantly (p < 0.05) higher than young animals. Our data also
show 8-hydroxyguanine levels in aged IP cortex of injured animals were significantly (p
< 0.05) increased compared to CON and IP cortices of aged animals subjected to sham
surgery (Figure 3.9). In hippocampus, we observed significantly (p < 0.05) higher levels
of 8-hydroxyguanine in middle aged and aged IP hippocampus compared to age matched
CON hippocampus. 8-hydroxyguanine levels in IP hippocampus of sham middle aged
and aged animals were also significantly increased compared to IP hippocampus of
young animals (Figure 3.10). FP, 8-OHA, FA and 5-OHC levels (Tables 3.2 and 3.3)
were not significantly different in IP hippocampus or cortex among the three age groups,
or between injured and sham animals.
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Table 3.1. HNE and acrolein levels and antioxidant enzyme activities in cortex in aging.
24 h post injury
7 days post injury
CON
IP
CON
IP
†
HNE
Young
100 ± 15.4
166.5 ± 17.8 100 ± 8.0
110.7 ± 16.0
Middle aged 100 ± 18.8
166.5 ± 29.9† 100 ± 7.8
371.7 ± 28.7*,†
†
148.2 ± 52.9$
Aged
100 ± 12.0
160.8 ± 22.7 100 ± 5.8
acrolein
Young
100 ± 13.0
103.1 ± 19.5 100 ± 3.5
104.7 ± 10.6
Middle aged 100 ± 10.1
104.4 ± 19.3 100 ± 1.0
179.3 ± 38.9*†
Aged
100 ± 6.9
115.2 ± 30.0 100 ± 0.5
169.2 ± 72.8*,#
MnSOD
Young
100 ± 41.0
98.7 ± 28.2
100 ± 8.3
73.2 ± 12.3†
Middle aged 100 ± 30.0
63.5 ± 27.2*,# 100 ± 21.2
61.1 ± 16.5†
Aged
100 ± 34.6
60.7 ± 20.8*,† 100 ± 26.5
48.4 ± 20.3†
†
Cu/ZnSOD Young
100 ± 21.7
71.9 ± 21.1
100 ± 8.4
77.7 ± 12.7†
Middle aged 100 ± 22.8
97.7 ± 37.0
100 ± 9.8
63.8 ± 23.7†
Aged
100 ± 16.2
92.4 ± 22.6
100 ± 30.7
54.1 ± 11.6†
GPx
Young
100 ± 14.9
116.4 ± 35.3 100 ± 19.9
149.2 ± 38.8#
Middle aged 100 ± 19.8
106.2 ± 30.3 100 ± 46.4
180.7 ± 106.3
Aged
100 ± 29.2
94.8 ± 40.2
100 ± 19.5
101.8 ± 31.0
GSSG-R
Young
100 ± 12.8
99.8 ± 20.0
100 ± 7.6
93.2 ± 22.5
Middle aged 100 ± 11.0
81.5 ± 14.1*,† 100 ± 27.3
66.0 ± 33.8
*,#
Aged
100 ± 20.9
82.0 ± 16.6
100 ± 25.2
102.2 ± 29.4
GST
Young
100 ± 15.21 81.5 ± 17.7†
100 ± 4.9
65.3 ± 23.3†
Middle aged 100 ± 11.6
69.6 ± 20.8†
100 ± 27.3
43.3 ± 18.6†
Aged
100 ± 20.2
70.5 ± 20.7†
100 ± 25.2
87.7 ± 28.9$, #
All values are mean ± SD. The value is percentage of that of CON tissue.* p < 0.05
compared with activities in young IP tissues at the same time point. $ p < 0.05 compared
with activities in middle aged IP tissues at the same time point. #p < 0.05, †p < 0.01
compared with activities in CON hippocampus of the corresponding age.
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8-Hydroxyguanine levles in IP and CON cortex
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Figure 3.9. 8-hydroxyguanine levels in cortex in TBI in aging. *p < 0.05 compared with
young and middle aged IP cortex of injured animals; #p < 0.05 compared with CON
cortex of injured aged animals; $p < 0.05 compared with aged CON cortex of injured
animals. Results are expressed as mean ± SD.

63

8-Hydroxyguanine levels in hippocampus in TBI in aging
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Figure 3.10. 8-hydroxyguanine levels in hippocampus in TBI in aging. *p < 0.05
compared with young IP hippo of injured animals, #p < 0.05 compared with young IP
hippo of sham animals, $p < 0.05 compared with age matched CON hippo of injured
animals. Results are expressed as mean ± SD.
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Table 3.2. DNA oxidation levels in cortex.

Young
animals
Middleaged
animals
Aged
animals

CON
cortex
IP
cortex
CON
cortex
IP
cortex
CON
cortex
IP
cortex

sham
injured
sham
injured
sham
injured
sham
injured
sham
injured
sham
injured

FG
105.4 ± 60.0
120.5 ± 63.2
154.0 ± 61.2
160.7 ± 79.8
160.2 ± 39.9
138.3 ± 75.6
206.2 ± 82.4
228.4 ± 91.4
202.8 ± 34.9
201.0 ± 86.3
207.8 ± 83.6
262.3 ± 114.7

Results are expressed as mean ± SD.
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8-OHA
7.4 ± 3.3
6.7 ± 3.0
13.0 ± 4.0
11.7 ± 4.6
9.5 ± 3.2
11.5 ± 3.6
15.0 ± 2.4
15.4 ± 5.8
11.4 ± 4.0
11.2 ± 2.6
16.6 ± 1.5
16.6 ± 7.1

FA
188.2 ± 111.7
168.0 ± 65.5
209.0 ± 81.9
279.0 ± 134.8
232.1 ± 103.4
167.9 ± 84.6
213.7 ± 102.6
299.6 ± 90.2
272.4 ± 78.3
267.4 ± 91.2
328.8 ± 141.4
289.0 ± 89.3

5-OHC
17.2 ± 7.3
13.5 ± 4.3
23.9 ± 9.7
23.5 ± 10.4
16.5 ± 3.4
18.7 ± 9.6
23.1 ± 5.3
29.8 ± 9.5
14.9 ± 3.9
19.3 ± 5.5
28.9 ± 4.4
27.8 ± 6.7

Table 3.3. DNA oxidation in hippocampus.

Young
animals
Middleaged
animals
Aged
animals

CON
hippo
IP hippo
CON
hippo
IP hippo
CON
hippo
IP hippo

sham
injured
sham
injured
sham
injured
sham
injured
sham
injured
sham
injured

FG
135.0 ± 39.5
133.5 ± 49.3
143.2 ± 49.4
159.7 ± 25.0
162.0 ± 64.0
161.2 ± 29.2
197.6 ± 51.3
242.3 ± 50.8
209.2 ± 60.5
255.8 ± 50.4
227.8 ± 64.2
308.2 ± 92.6

Results are expressed as mean ± SD.
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8-OHA
7.9 ± 5.0
10.1 ± 4.6
10.5 ± 7.6
12.5 ± 5.0
11.1 ± 5.3
10.2 ± 3.7
10.2 ± 3.8
10.1 ± 3.6
10.1 ± 9.6
10.6 ± 5.7
13.3 ± 9.7
8.8 ± 2.5

FA
207.7 ± 104.8
314.7 ± 216.7
326.4 ± 52.4
333.2 ± 114.5
309.4 ± 66.1
310.8 ± 128.4
346.5 ± 133.1
313.0 ± 78.6
338.2 ± 152.3
341.7 ± 75.0
347.3± 78.7
425.2 ± 151.6

5-OHC
19.1 ± 9.8
17.3 ± 9.1
14.3 ± 5.3
20.3 ± 3.7
22.5 ± 5.2
21.0 ± 5.6
24.1 ± 5.1
24.2 ± 8.0
19.6 ± 6.4
24.9 ± 7.1
23.4 ± 6.3
30.3 ± 5.8

3.1.7 Antioxidant Enzyme Activities in IP Hippocampus and Cortex in Aging
Measurement of markers of lipid peroxidation showed increased oxidative
damage in aging following TBI. To determine if alterations in antioxidant enzyme
capacity occurred as a function of age, Cu/Zn and MnSOD, GPx, GSSG-R and GST
activities were determined in IP and CON hippocampus and cortex 24 h and 7 days post
injury. The data from IP tissues were expressed as a percentage of CON tissues. At 24 h
post injury, the hippocampus showed a trend toward decreased MnSOD activity (p < 0.1)
for aged animals compared to aged CON hippocampus (Table 3.4). ANOVA showed a
significant age dependent decrease of MnSOD [F(2,27) = 4.54, p < 0.05] in IP
hippocampus, with a more pronounced loss of MnSOD activity (p < 0.05) in aged
animals compared with middle aged animals. At 7 days post injury, our data showed
MnSOD activities in aged animals decreased significantly (p < 0.01) compared with aged
CON hippocampus, but not for young and middle-aged animals (Table 3.4). ANOVA
[F(2,20) = 3.5004, p < 0.05] showed an age dependent decrease of MnSOD activity in IP
hippocampus, with aged animals showing significantly lower activities compared with
young animals. In IP cortex, our data showed MnSOD activity decreased significantly (p
< 0.01) in middle aged and aged animals compared with their age matched CON cortices
and also IP cortices of young animals 24 h post injury [F(2,25) = 5.9072, p < 0.01] (Table
3.1). At 7 days post injury, young, middle aged and aged animals all showed significant
(p < 0.01) depletion of MnSOD compared to their corresponding CON cortices, although
there were no significant age dependent changes at this time point (Table 3.1).
Analysis of Cu/ZnSOD activities showed no significant changes in IP hippocampus
compared to CON tissues at 24 h post injury (Tables 3.1, 3.4). In cortex, Cu/ZnSOD
activity deceased significantly in IP cortex compared with CON cortex for young animals
at 24 h post injury. At 7 days post injury, Cu/ZnSOD activity decreased significantly in
IP cortex compared to CON cortex for each age animals (Table 3.4). However, there
were no age dependent changes observed for this enzyme activity at any time point.
Levels of GPx, which reduces oxidative stress by converting H2O2 and a
variety of organic peroxides to stable alcohols and water, showed a trend of increase in
young IP hippocampus 24 h post injury (Table 3.4). Only slight changes were observed in
response to injury in middle aged and aged IP hippocampus (Table 3.4).
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Table 3.4. Antioxidant enzyme activities in hippocampus in aging.

MnSOD

Young
Middle aged
Aged
Cu/ZnSOD Young
Middle aged
Aged
GPx
Young
Middle aged
Aged
GSSG-R
Young
Middle aged
Aged
GST
Young
Middle aged
Aged

24 h post injury
CON
IP
100 ± 21.1
97.7± 19.8
100 ± 24.9
111.8 ± 23.5
100 ± 26.4
83.9 ± 17.9$
100 ± 18.5
104.3 ± 22.5
100 ± 21.7
115.8 ± 50.5
100 ± 17.0
113.4 ± 24.7
100 ± 31.6
169.3 ± 68.9
100 ± 41.0
111.0 ± 39.7*
100 ± 26.4
99.6 ± 20.0*
100 ± 9.3
111.2 ± 13.6
100 ± 7.6
107.4 ± 8.8
100 ± 9.9
108.4 ± 18.0
100 ± 7.3
95.9 ± 8.1
100 ± 10.4
92.8 ± 12.6
100 ± 17.7
94.1 ± 13.5

7 days post injury
CON
IP
100 ± 19.1
95.8 ± 24.6
100 ± 22.8
66.7 ± 38.9
100 ± 22.7
71.2 ± 8.9*†
100 ± 19.2
95.8 ± 10.1
100 ± 33.4
129.5± 71.6
100 ± 25.2
105.1 ± 12.1
100 ± 32.0
143.9 ± 88.0
100 ± 19.2
113.4 ± 13.1
100 ± 13.2
107.2 ± 14.0
100 ± 9.4
98.1 ± 24.2
100 ± 8.8
89.3 ± 6.1†
100 ± 7.6
87.5 ± 8.7†
100 ± 12.0
94.3 ± 16.6
100 ± 14.4
84.8 ± 14.6
100 ± 8.1
87.7 ± 5.7†

All values are mean ± SD. The value is percentage of that of CON tissue.

*

p < 0.05

compared with activities in young IP tissues at the same time point. $ p < 0.05 compared
with activities in middle aged IP tissues at the same time point. †p < 0.01 compared with
activities in CON hippocampus of the corresponding age.
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Statistical analysis showed GPx activity was significantly lower (p < 0.05) in middle aged
and aged animals compared to young animals 24 h post injury in IP hippocampus. In IP
cortex, GPx activity did not change significantly in any age group 24 h post injury,
although levels increased significantly (p < 0.05) in young animals 7 days post injury
(Table 3.1).
Glutathione transferase activities showed a significant decrease (p < 0.01) in IP
cortices in young, middle aged and aged animals 24 h post injury compared with their
CON cortices. At 7 days post injury, GST activities in young and middle aged IP cortices
were also decreased significantly (p < 0.01) compared to CON cortices.

ANOVA

showed GST activity was significantly lower in middle aged animals compared with aged
animals at this time point (Table 3.1). In IP hippocampus, GST activities decreased
significantly (p < 0.01) in aged animals compared with their corresponding CON
hippocampi at 7 days post injury. However, no age dependent changes were observed at
24 h or 7 days post injury (Table 3.4).
Another antioxidant enzyme, GSSG-R, which functions to reduce oxidized GSH
to reduced GSH for participation in the GSH reaction, was significantly depleted in IP
cortex (p < 0.01) of middle aged and aged animals compared to their CON cortices 24 h
post injury. ANOVA showed GSSG-R activities were significantly (p < 0.05) lower in
middle aged and aged animals compared with young animals at this time point (Table
3.1). In IP hippocampus, GSSG-R activity did not change significantly compared to CON
hippocampus for any age group 24 h post injury. At 7 days post injury, GSSG-R activity
decreased significantly (p < 0.01) in middle aged and aged animals compared with their
corresponding CON hippocampus. Our data showed no age dependent differences at
either time point in IP hippocampus (Table 3.4).
3.2 Protection of Creatine in TBI
Considerable research and effort has been directed toward finding efficient
therapeutics that may reduce secondary injury, including oxidative damage. Although no
breakthrough was emerged to date, some drug candidates have recently arisen. Creatine
has been shown to be neuroprotective in other neurodegenerative diseases, although there
has been limited study in TBI. In the current study, we evaluated creatine on oxidative
damage in TBI.
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3.2.1 HNE and Acrolein Relative Content in Hippocampus of Young Animals with
Creatine Supplementation
The hippocampus is subject to mild mechanical injury in TBI, and experiences
delayed secondary injury, including oxidative damage, which could trigger or accelerate
neuron death in this tissue and result in memory deficits. Our previous study showed
extensive oxidative stress in IP cortex and hippocampus 24 h post injury in animals
following TBI. Creatine has been shown to ameliorate oxidative damage in TBI. To
determine the effects of creatine on lipid peroxidation and antioxidant capacities, we
measured oxidative damage using markers of lipid peroxidation at 24 h post injury in
animals provided a creatine supplemented diet. Our data show HNE levels in IP
hippocampus of animals treated with creatine decreases significantly (p < 0.05) compared
to animals provided a control diet [F(2,23) = 4.3897, p < 0.05] (Figure. 3.11). Another
lipid peroxidation marker, acrolein, showed the same trend in the three groups although it
was not statistically significant (Figure. 3.11). No significant changes were observed for
HNE or acrolein in IP hippocampi from animals treated with 1% and 2% creatine. For
HNE and acrolein levels in CON hippocampus, there were no significant differences
between creatine treated and control animals
3.2.2 HNE and Acrolein Relative Content in Cortex of Young Animals provided
Creatine Supplementation
In cortex, mechanical injury triggers cell necrosis and apoptosis, with
production of ROS and toxic byproducts of lipid peroxidation, including HNE and
acrolein. Analysis of levels of HNE modified proteins in IP cortex showed that HNE
protein adducts decreased significantly (p < 0.05) in IP cortex in animals provided 1%
creatine supplemented diet compared to animals on a control diet [F(2,23) = 4.2013, p <
0.05] (Figure. 3.12). Similarly, acrolein decreased as a trend in animals provided creatine
diets. In CON cortex there were no significant changes in HNE or acrolein levels
between control and creatine treated animals.
3.2.3 Antioxidant Enzyme Activities in Hippocampus and Cortex of Young Animals
with Creatine Supplementation
Measurement of markers of lipid peroxidation showed increased oxidative stress
in TBI. Creatine has shown protective effects in a variety of neurodegenerative disease,
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HNE and acrolein levels in hippocampus
180
160

control

*p < 0.05

1% creatine
2% creatine

% of control
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120

*

100
80

*
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40
20
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CON

IP
HNE

CON

IP
acrolein

Figure 3.11. 4-Hydroxynonenal and acrolein levels in hippocampus following TBI. Bars
represent mean ± SD of control. p* < 0.05 compared with control animals with regular
diet.
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HNE and acrolein levels in cortex
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*p < 0.05

control

1% creatine
2% creatine

140

% of control

120

*
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20
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CON
HNE

IP

CON
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acrolein

Figure 3.12. 4-Hydroxynonenal and acrolein levels in hippocampus following TBI. Bars
represent mean ± SD of control.
*

p < 0.05 compared with control animals with regular diet.

72

including TBI. Our data showed reduced lipid peroxidation in animals on a creatine diet
24 h post injury. To determine if protective effects of creatine supplementation in TBI are
due to enhanced antioxidant capacities, activities of Cu/Zn and Mn SODs, GPx, GSSG-R
and GST were determined in IP and CON hippocampus and cortex 24 h post injury. Our
data show increased MnSOD activity [F(2,23) = 4.0551, p < 0.05] in IP hippocampus of
animals with both 1% and 2% creatine diets compared to controls (Table 3.5). In CON
hippocampus, MnSOD activity increased in 1% and 2% creatine treated animals, but did
not reach statistical significance. In IP and CON cortex, our data showed creatine
supplementation did not significantly improve MnSOD activity (Table 3.6).
Our data showed Cu/ZnSOD activities increased significantly (p < 0.05) in IP
hippocampus of 1% and 2% creatine treated animals relative to controls [F(2,23) =
3.9727, p < 0.05] (Table 3.5). In IP cortex, Cu/ZnSOD activity also increased
significantly in creatine treated animals compared to controls (Table 4.6). No significant
differences in Cu/ZnSOD were observed in CON tissues between creatine treated and
control animals (Tables 3.5 and 3.6).
Levels of GPx, which reduces oxidative stress by converting H2O2 and a variety
of organic peroxides to corresponding stable alcohols and water, showed
significant decreases in IP hippocampus of animals treated with 1% creatine but not 2%
(Table 3.5). In IP cortex, GPx also decreased in creatine treated animals compared to
controls (Table 3.6).
Glutathione transferase activities showed a significant increase (p <0.05) in IP
hippocampus in 2% creatine treated animals compared with controls [F(2,23) = 7.5320, p
< 0.01] (Table 3.5). In both IP and CON cortex and CON hippocampus, there were no
significant changes in GST activity between control and creatine treated animals (Tables
3.5 and 3.6).
Another antioxidant enzyme, GSSG-R which functions to reduce oxidized GSH
to reduced GSH as the substrate for the GPx reaction, was significantly (p < 0.05)
increased in IP cortex of 1% and 2% creatine treated animals relative to controls (Table
3.6). There were no significant changes in IP or CON hippocampus or CON cortex
(Tables 3.5 and 3.6).
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Table 3.5. Antioxidant enzyme activities in hippocampus.
IP hippo

MnSOD

Cu/ZnSOD

GPx

GSSG-R

GST

control

100.0±25.9

100.0±17.9

100.0±17.3

100.0±11.3

100.0±5.9

1% creatine 126.8±28.1*

122.8±18.5*

66.3±11.3*

103.2±12.3

106.5±16.2

2% creatine 127.1±19.7*

121.7±18.2*

86.1±24.3

95.7±11.2

121.0±8.3*

100.0±34.0

100.0±14.0

100.0±16.4

100.0±10.7

100.0±15.2

1% creatine 118.6±19.1

115.3±17.0

98.7±18.8

105.4±22.9

95.7±13.7

2% creatine 130.6±18.5

109.8±9.0

108.7±31.0

97.2±11.0

105.6±15.3

CON hippo
control

p* < 0.05 compared with control.
Data were expressed as percent of control, mean ± SD
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Table 3.6. Antioxidant enzyme activities in cortex.
IP cortex

MnSOD

Cu/ZnSOD

GPx

GSSG-R

GST

control

100.0±11.0

100.0±15.3

100.0±7.3

100.0±10.3

100.0±9.0

1% creatine 101.3±27.9

117.2±12.1*

71.8±8.3*

120.2±21.3* 103.6±23.9

2% creatine 112.6±29.1

126.1±17.0*

71.8±15.1*

122.1±17.9* 102.4±22.5

100.0±12.9

100.0±16.4

100.0±22.4

100.0±18.4

100.0±18.1

1% creatine 103.2±18.5

104.7±11.3

108.1±13.1

100.6±16.1

96.6±14.5

2% creatine 110.3±14.5

96.7±7.7

118.8±57.1

94.7±14.6

103.6±13.3

CON cortex
control

p* < 0.05 compared with control.
Data were expressed as percent of control, mean ± SD
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3.3 Mitochondrial Proteomics
Mitochondria function as a signaling center, calcium sink and major ROS source
in the cell, and previous study showed compromised respiration chain and calcium
sequestion capacity following TBI. The current study shows increased oxidative damage
and decreased antioxidant enzyme activities, especially MnSOD, suggesting there could
be significant changes in mitochondria following TBI. In order to uncover the changes in
mitochondria, mitochondrial protein levels were evaluated.
Isotope-coded affinity tag (ICAT) proteomics is a very efficient method to
compare protein levels in two different samples. Although most proteomic studies use 2D
gel electrophoresis, the amount of protein necessary for analysis limits its usefulness
when only small amounts of protein are available as observed for mitochondria. To
analyze differences in mitochondrial protein levels the use of ICAT proteomics is the
most appropriate choice because it only requires 100 μg proteins from each sample for
analysis. In the current study, using ICAT labeling 2D LC-MS/MS, mitochondrial
proteins isolated from cortex and hippocampus at 1 h or 24 h post injury were quantified
to examine individual protein changes.
3.3.1 Evaluation of ICAT Labeling for 2D LC-MS/MS
In this study, ICAT labeling and 2D LC-MS/MS was first evaluated using two
aliquots of mitochondrial sample from the same pool for heavy and light ICAT reagent
labeling and MS quantification. Our analyses identified 60 unique proteins of which
63.3% identified with multiple unique peptides. Most of these proteins (73.3%) were
mitochondrial based on SwissProt database, which suggest mitochondria were enriched
by Percoll gradient centrifugation. The mean of heavy to light ratios of all the
mitochondrial proteins identified from the experiment was 1.06 ± 0.24, showing that the
ICAT method is reliable to quantify protein expression changes (Table 3.7). However, it
indicates variations in the methods.
3.3.2 Proteomic Analysis of Differentially Expressed Mitochondrial Proteins in
Cortices 1 h and 24 h Post Injury
In this study, enriched mitochondria were isolated from IP or CON cortex
of sham and injured animals 1 and 24 h post injury, and protein expression evaluated
using ICAT labeling and 2D LC-MS/MS. Tissues were pooled and mitochondria isolated
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Table 3.7. Protein identified from one experiment using same sample for heavy and light
labeling.
Protein Name

Sodium/potassium-transporting ATPase alpha3 chain
Aspartate aminotransferase
Acyl coenzyme A thioester hydrolase 2
Acyl-CoA dehydrogenase family member 9
ADP,ATP carrier protein, heart/skeletal muscle
isoform T1
Sarcoplasmic/endoplasmic reticulum calcium
ATPase 2
Sodium/potassium-transporting ATPase beta-1
chain
ATP synthase alpha chain
ATP synthase gamma chain
ATP synthase D chain
60 kDa heat shock protein
Cytochrome c oxidase polypeptide Vb
Cytochrome c oxidase polypeptide VIb
Calreticulin precursor
Cytochrome c1, heme protein
Glutamate dehydrogenase
Dihydroperidine reductase
4-aminobutyrate aminotransferase
Guanine nucleotide-binding protein
Glutaminase, kidney isoform
Glycerol-3-phosphate dehydrogenase
Hemoglobin beta chain, major-form
Hexokinase, type I
Isocitrate dehydrogenase [NAD] subunit
gamma
cAMP-dependent protein kinase type II-alpha
chain
Creatine kinase, B chain
Creatine kinase, ubiquitous mitochondrial
Hematopoietic stem/progenitor cells protein
MDS029 homolog
Malate dehydrogenase
NADH-ubiquinone oxidoreductase B18
subunit
NADH-ubiquinone oxidoreductase PDSW
subunit
NADH-ubiquinone oxidoreductase 15 kDa
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SwissProt

Xpress

StDev

(P06687)
(P05202)
(Q9R0X4)
(Q8JZN5)

0.78
0.93
0.79
0.71

0.66

1
5
1
2

(P48962)

1.20

0.18

3

(P11507)

1.02

1

(P14094)
(Q03265)
(Q91VR2)
(P31399)
(P19226)
(P19536)
(P56391)
(P14211)
(Q9D0M3)
(P26443)
(P11348)
(P61922)
(P54311)
(P13264)
(P35571)
(P02091)
(P17710)

0.75
0.88
0.91
1.39
0.82
1.14
1.74
0.80
0.99
0.77
0.87
0.95
1.06
0.97
1.04
1.01
0.94

0.21

1
2
10
4
2
1
4
1
8
8
2
7
1
8
1
1
8

(P70404)

1.04

0.24

4

(P12367)
(Q04447)
(P30275)

1.04
1.16
1.15

0.18

1
1
2

(Q91WS0)
(P08249)

1.40
1.20

0.42
0.40

3
20

(Q9CR61)

0.86

0.28

3

(Q9DCS9)
(Q99LY9)

1.14
1.21

0.39
0.16

3
2

0.26

0.22
0.16
0.54
0.00
0.85
0.16
0.20
0.01
0.26
0.37

NumPep

subunit
NADH-ubiquinone oxidoreductase 75 kDa
subunit
NADH-ubiquinone oxidoreductase 24 kDa
subunit
NADH-ubiquinone oxidoreductase 19 kDa
subunit
2-Oxoglutarate dehydrogenase E1 component
Dihydrolipoyllysine-residue acetyltransferase
component of pyruvate
dehydrogenase
Pyruvate dehydrogenase E1 component alpha
subunit
Pyruvate dehydrogenase E1 component beta
subunit
Mitochondrial precursor proteins import
receptor
Dynamin-like 120 kDa protein
Proliferation-associated protein 2G4
Voltage-dependent anion-selective channel
protein 1
Voltage-dependent anion-selective channel
protein 3
Peptidyl-prolyl cis-trans isomerase A
Pyruvate carboxylase
Retinoblastoma-like protein 1
60S ribosomal protein L18a
40S ribosomal protein S11
Sulfated glycoprotein 1 precursor
Succinyl-CoA ligase [ADP-forming] betachain
Suppressor of cytokine signaling 4
Succinate semialdehyde dehydrogenase
Synaptophysin
Acetyl-CoA acetyltransferase
Thiosulfate sulfurtransferase
Ubiquinol-cytochrome-c reductase complex
core protein 2
Ubiquinol-cytochrome C reductase complex 11
kDa protein
Hypothetical protein C030036P15Rik
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(Q91VD9)

0.96

0.16

4

(Q9D6J6)

1.25

-

2

(Q9DCJ5)
(Q60597)

1.01
0.96

0.24
0.25

5
5

(P08461)

2.08

(P35486)

1.54

0.23

4

(Q9D051)

0.87

0.17

3

1

(Q9CZW5) 1.14
(P58281)
1.10
(P50580)
1.72

1
1
1

(Q60932)

1.25

0.33

2

(Q9R1Z0)
(P10111)
(Q05920)
(Q64701)
(P62717)
(P62281)
(Q61207)

1.02
1.35
0.78
0.78
1.20
1.30
1.16

0.21

10
1
2
1
2
1
1

(Q9Z2I9)
(Q9JLY0)
(P51650)
(Q62277)
(P17764)
(P52196)

0.97
1.19
0.61
0.65
1.60
1.57

0.21
0.49

3
1
1
1
2
2

(Q9DB77)

1.20

0.26

8

(P99028)
1.34
(Q8BQM4) 1.30

0.21
0.16

3
3

0.04
0.00

0.25

as described labeling and 2D LC-MS/MS. Tissues were pooled and mitochondria isolated
as described in methods and materials, and pooled samples were run triplicate to look at
proteins with prominent changes (Figure 3.13) and reduce variations exist in the current
method (Yi et al., 2002; Zhang et al., 2005). The results were combined with proteins
identified in more than two independent experiments for each pool sample, and the
proteins identified in each pool were combined. A total of 195 proteins were identified in
this study using quantatitive proteomics, and 37 proteins were identified at each time
point in both IP and CON tissues (Table 3.8). Fourteen proteins were identified with
significant changes in at least either IP or CON tissues, or either time point post injury
(Tables 3.9, 3.10). Major protein classes include those related to oxidative
phosphorylation, the electron transport chain, and carrier proteins.
Several proteins involved in the respiratory chain were identified in our study. In
complex III, cytochrome c1 was significantly increased (36%, p = 0.0006) 1 h post injury
in CON cortex, but reduced (27%, p = 0.000) 24 h post injury. Ubiquinol-cytochrome-c
reductase complex core protein 2 was reduced (31%) as a trend (p = 0.0366) 24 h post
injury in IP cortex, and slightly but statistically significantly (13%, p = 0.0014) decreased
in CON cortex at this time point. At 1 h post injury, this complex III core protein
increased significantly (29%, p = 0.000) in CON cortex. Our data show that cytochrome c
oxidase polypeptide Vb (cox5b), a component of complex IV, decreased significantly in
both IP (32%, p = 0.000) and CON (26%, p = 0.000) cortex 24 h post injury. At 1 h post
injury, cox5b did not change significantly in either IP or CON cortex. Cytochrome c
oxidase polypeptide VIb (cox6b1), another complex IV subunit, decreased significantly
24 h post injury in IP (24%, p = 0.000) cortex.
Analyses of proteins in the TCA cycle show that 2-oxoglutarate dehydrogenase
E1 component decreased significantly (25%, p = 0.000) in IP cortex 24 h post injury, and
increased (41%, p = 0.0244) as a trend in CON cortex at 1 h post injury. Dihydrolipoyl
(dihydrolipoamide) dehydrogenase, a component of the glycine cleavage system as well
as of the alpha-ketoacid dehydrogenase complexes, decreased (19%) significantly (p =
0.000) in IP cortex 24 h post injury, and increased (16%, p = 0.0052) as a trend in CON
cortex 1 h post injury.
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CON 1 h
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1
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3
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3

Mitochondrial proteins identified
in cortex or hippocampus were
pooled for each group of animals.

Proteins identified
at each time point in
both IP and CON
tissues.

Figure 3.13. Protein organization.
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Table 3.8. Proteins identified in both IP and CON cortex at 1 and 24 hour post injury.
SwissProt annotated biological
Common name
SwissProt location
process
amino acid
Aspartate aminotransferase
P00507
Mitochondrial matrix metabolism
Mitochondrial inner
ADP,ATP carrier protein
P48962
membrane
carrier
Mitochondrial inner
ATP synthase alpha chain
Q03265
membrane
OXPHOS
ATP synthase gamma chain
Q91VR2 Mitochondrial
OXPHOS
ATP synthase D chain
P31399
Mitochondrial
OXPHOS
protein
60 kDa heat shock protein
P63038
Mitochondrial matrix import/assembly
2',3'-cyclic-nucleotide 3'phosphodiesterase
P16330
membrane
cell defense
Cytochrome c oxidase
Mitochondrial inner
polypeptide Vb,
p12075
membrane
OXPHOS
Mitochondrial
Cytochrome c1, heme protein
Q9D0M3 intermembrane space OXPHOS
Glutamate dehydrogenase
P26443
Mitochondrial matrix TCA cycle
amino acid
Dihydrolipoyl dehydrogenase
O08749
Mitochondrial matrix metabolism
Glyceraldehyde-3-phosphate
dehydrogenase
Q64467
Cytoplasmic
glycolysis
4-aminobutyrate
amino acid
aminotransferase
P61922
Mitochondrial matrix metabolism
amino acid
Glutaminase
P13264
Mitochondrial
metabolism
outer mitochondrial
Hexokinase, type I
P05708
membrane
glycolysis
Isocitrate dehydrogenase
[NAD] subunit gamma
P70404
Mitochondrial
TCA cycle
energy
Creatine kinase, B chain
Q04447
Cytoplasmic
transduction
Creatine kinase, ubiquitous
Mitochondrial inner energy
mitochondrial
P30275
membrane
transduction
Malate dehydrogenase
P04636
Mitochondrial matrix TCA cycle
Matrix side of
NADH-ubiquinone
mitochondrial inner
oxidoreductase 51 kDa
Q91YT0 membrane
OXPHOS
NADH-ubiquinone
Mitochondrial inner
oxidoreductase 13 kDa
P52504
membrane
OXPHOS
Alpha-ketoglutarate
dehydrogenase
Q60597
Mitochondrial matrix TCA cycle
Ubiquinol-cytochrome-c
Mitochondrial inner
reductase complex
Q9DB77 membrane
OXPHOS
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core protein 2
Ubiquinol-cytochrome C
reductase complex 11 kDa
protein
Sodium/potassium-transporting
ATPase alpha-1 chain
precursor
Sodium/potassium-transporting
ATPase alpha-3 chain
Calcium-binding mitochondrial
carrier protein Aralar1
Cytochrome c oxidase
polypeptide VIb
Mitochondrial glutamate
carrier 1
Uncharacterized hematopoietic
stem/progenitor call protein
MDs029 homolog
NADH-ubiquinone
oxidoreductase 19 kDa
subunit
Voltage-dependent anionselective channel protein 1
(VDAC-1)
Voltage-dependent anionselective channel protein 3
(VDAC-3)

P99028
Q8VDN2
Q6PIC6
Q8BH59
P56391

Mitochondrial inner
membrane
Integral membrane
protein
Integral membrane
protein
Mitochondrial inner
membrane

OXPHOS
transport
transport
transport
OXPHOS

Q9D6M3

Mitochondrial
Mitochondrial inner
membrane

Q91ws0

unknown

unknown

Q9DCJ5

Mitochondrial

OXPHOS

Q60932

outer membrane of
mitochondria

channels

transport

Outer mitochondrial
membrane
channels
Cytoplasmic,
Syntaxin binding protein 1
peripheral membrane
(Unc-18 homolog)
O08599
protein
signaling
Integral membrane
Synaptophysin
Q62277
protein
signaling
Tubulin beta-3
Q9ERD7 cytoskeleton
structure
Tubulin beta-4 chain
Q9D6F9
cytoskeleton
structure
Note: each protein was identified in at least two experiments at each time point in CON
and IP cortices.
Q9R1Z0
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Table 3. 9. Cortical mitochondrial proteins.
1h IP
protein

ratio

Cytochrome c1, heme
1.08 ± 0.20
protein
Ubiquinol-cytochrome-c
reductase complex core
0.92 ± 0.1
protein 2
Cytochrome c oxidase
1.03 ± 0.31
polypeptide Vb
Cytochrome c oxidase
0.87 ± 0.18
polypeptide VIb
Dihydrolipoyl
1.05 ± 0.09
dehydrogenase
Alpha-ketoglutarate
1.08 ± 0.23
dehydrogenase
1.00 ± 0.03
Hexokinase, type I
Glyceraldehyde-31.24 ± 0.37
phosphate dehydrogenase
Creatine kinase,
1.07 ± 0.25
ubiquitous mitochondrial
1.42 ± 0.04
ANT1
1.11 ± 0.43
Aralar1
Mitochondrial glutamate
1.12 ± 0.47
carrier 1
1.31 ± 0.41
VDAC1
1.04 ± 0.30
VDAC3
Data were expressed as mean ± SD.
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24h IP
p

ratio

p

0.4778

0.73 ± 0.08

0.000

0.238

0.69 ± 0.21

0.0366

0.865

0.68 ± 0.11

0.000

0.3174

0.76 ± 0.05

0.000

0.3844

0.81 ± 0.08

0.000

0.617

0.75 ± 0.07

0.000

0.9362

0.82 ± 0.06

0.000

0.3574

2.02 ± 0.67

0.0316

0.617

3.62 ± 3.87

0.242

0.000
0.7338

2.18 ± 1.95
0.71 ± 0.21

0.3954
0.0524

0.660

0.72 ± 0.23

0.097

0.190
0.8494

0.80 ± 0.11
0.80 ± 0.03

0.001
0.000

Table 3. 10. Cortical mitochondrial proteins.
protein

1h CON
ratio

Cytochrome c1, heme
1.36 ± 0.18
protein
Ubiquinol-cytochrome-c
reductase complex core
1.29 ± 0.01
protein 2
Cytochrome c oxidase
1.23 ± 0.20
polypeptide Vb
Cytochrome c oxidase
1.02 ± 0.22
polypeptide VIb
Dihydrolipoyl
1.16 ± 0.10
dehydrogenase
Alpha-ketoglutarate
1.41 ± 0.26
dehydrogenase
1.43 ± 0.64
Hexokinase, type I
Glyceraldehyde-30.90 ± 0.05
phosphate dehydrogenase
Creatine kinase, ubiquitous
1.24 ± 0.03
mitochondrial
1.29 ± 0.35
ANT1
1.26 ± 0.09
Aralar1
Mitochondrial glutamate
1.62 ± 0.08
carrier 1
1.05 ± 0.15
VDAC1
1.30 ± 0.25
VDAC3
Data were expressed as mean ± SD.
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p

24h CON
ratio
p

0.0006

0.92 ± 0.22

0.5352

0.000

0.87 ± 0.06

0.0014

0.1586

0.74 ± 0.10

0.000

0.8494

0.80 ± 0.43

0.5156

0.0052

1.03 ± 0.29

0.8572

0.0244

0.94 ± 0.39

0.7794

0.2984

0.91 ± 0.17

0.3788

0.0028

0.91 ± 0.03

0.000

0.000

0.91 ± 0.17

0.2584

0.246
0.000

0.93 ± 0.07
1.10 ± 0.42

0.1528
0.6818

0.000

0.94 ± 0.08

0.3174

0.5286
0.0854

0.96 ± 0.16
1.09 ± 0.12

0.6242
0.2006

Our analysis also identified several proteins involved in glycolysis, NADH
transport and mitochondrial transition pore (MTP) formation. Glyceraldehyde-3phosphate dehydrogenase functions in glycolysis and apoptosis, and was increased in IP
cortex 24 h post injury as a trend, and decreased significantly in CON cortex at 1 (10%, p
= 0.0028) and 24 h (9%, p = 0.000) post injury respectively. Hexokinase 1, a component
of glycolysis and MTP formation, decreased significantly (18%, p = 0.000) in IP cortex
24 h post injury, but did not change significantly in CON cortex 1 and 24 h post injury, or
in IP cortex at 1 h post injury. Creatine kinase is involved in energy transport and MTP
formation, and was increased significantly (24%, p = 0.000) 1 h post injury in CON
cortex. Carrier proteins, aralar1 and cintrin were increased significantly (26%, p = 0.000
and 62%, p = 0.000, respectively) 1 h post injury in CON cortex, and decreased as a trend
(29%, p = 0.0524 and 28%, p = 0.097, respectively) 24 h post injury in IP cortex.
ADP/ATP carrier protein increased (42%) significantly (p = 0.000) 1 h post injury in IP
cortex. VDAC proteins (VDAC1 and VDAC3), channel proteins for metabolite exchange
across outer membrane and members of the MTP, decreased significantly (p = 0.001 for
VDAC1 and p = 0.000 for VDAC3) in IP cortex 24 h post injury (Table 3.9).
3.3.3 Proteomic Analysis of Differentially Expressed Mitochondrial Proteins in
Hippocampi 1 h and 24 h Post Injury
In this study, enriched mitochondria were isolated from IP and CON hippocampus
of sham and injured animals 1 and 24 h post injury and were processed as described
above. Mitochondrial proteins from four independent samples were pooled again, and
samples from each pool were run in triplicate to examine proteins with prominent
changes. A total of 29 proteins were identified at each time point in both IP and CON
tissues (Table 3.11). Twenty proteins were identified with significant changes in either IP
or CON tissues, at either time point post injury (Tables 3.12, 3.13). Major classes include
those related to oxidative phosphorylation and transport.
Several proteins involved in the respiratory chain were identified in this study.
NADH-ubiquinone oxidoreductase B18 subunit, a component of complex I, was
significantly decreased (30%, p = 0.0025) in IP hippocampus but significantly increased
26% (p = 0.0012) in CON hippocampus 24 h post injury. Cytochrome c1, a component of
complex III, was increased (26%) as a trend (p = 0.0078) in CON hippocampus 24 h post

85

Table 3. 11. Proteins identified in both IP and CON hippocampus at 1 and 24 hour post
injury.
Common name
Calcium\calmodulindependent protein kinase
type II alpha chain
Synaptophysin
Sodium\potassiumtransporting ATPase alpha-3
chain
Tubulin beta-5 chain
Tubulin alpha-2 chain
2',3'-cyclic-nucleotide 3'phosphodiesterase
Mitochondrial glutamate
carrier 1
Aspartate aminotransferase
Glutamate dehydrogenase 1
Voltage-dependent anionselective channel protein 3
60 kDa heat shock protein,
mitochondrial precursor
ATP synthase gamma chain
Malate dehydrogenase
Voltage-dependent anionselective channel protein 1
Creatine kinase, ubiquitous
mitochondrial precursor
Ubiquinol-cytochrome c
reductase complex 11 kDa
protein
Citrate synthase
Isocitrate dehydrogenase
[NAD] subunit alpha
Dihydrolipoyl
dehydrogenase
Aconitate hydratase

SwissProt annotated
SwissProt location

Biological
process

p11275
p07825

postsynaptic lipid rafts
integral membrane protein

signaling
signaling

P06687
P69897
Q6P9V9

membrane protein
cytoskeleton
cytoskeleton

transport
structure
structure

P13233

membrane
mitochondrial inner
membrane

cell defense

Q9D6M3
P00507
P10860
Q9R1Z0
P63039
P35435
P04636

mitochondrial matrix
mitochondrial matrix
mitochondrial outer
membrane

P30275

mitochondrial matrix
mitochondrial
mitochondrial matrix
mitochondrial outer
membrane
mitochondrial inner
membrane

P99028
Q9CZU6

mitochondrial inner
membrane
mitochondrial matrix

Q9D6R2

mitochondrion

Q6P6R2
Q9ER34

mitochondrial matrix
mitochondrion
mitochondrial inner
membrane
outer mitochondrial
membrane
mitochondrial inner
membrane; matrix side

Q9Z2L0

ATP synthase subunit alpha

P15999

Hexokinase-1
Ubiquinol-cytochrome-c
reductase complex core

P05708
P32551
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transport
amino acid
metabolism
TCA cycle
channels
protein import
and assembly
OXPHOS
TCA cycle
channels
energy
transduction
OXPHOS
TCA cycle
TCA cycle
amino acid
metabolism
TCA cycle
OXPHOS
glycolysis
OXPHOS

protein 2
ADP\ATP translocase 1
Cytochrome c1, heme
protein
Mitochondrial precursor
proteins import receptor
NADH-ubiquinone
oxidoreductase B18 subunit
Excitatory amino acid
transporter 2
Calcium-binding
mitochondrial carrier protein
aralar1

mitochondrial inner
membrane
mitochondrial
Q9D0M3 intermembrane space
mitochondrial outer
Q9CZW5 membrane
mitochondrial inner
Q9CR61 membrane

OXPHOS

P43006

Membrane

transport

Q8BH59

mitochondrial inner
membrane

transport

P48962
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transport
OXPHOS
receptor

Table 3. 12. Hippocampal mitochondrial proteins
protein
NADH-ubiquinone
oxidoreductase B18 subunit
Ubiquinol-cytochrome-c
reductase core protein 2
Cytochrome c1, heme protein
Ubiquinol-cytochrome c
reductase 11 kDa protein
ATP synthase gamma chain
ATP synthase subunit alpha
Aspartate aminotransferase
Glutamate dehydrogenase 1
Malate dehydrogenase
Citrate synthase
Isocitrate dehydrogenase subunit
α
Dihydrolipoyl dehydrogenase
Hexokinase-1
ADP\ATP translocase ANT1
Mitochondrial precursor proteins
import receptor (TOM70)
Aralar1
VDAC1
VDAC3
60 kDa heat shock protein
Data were expressed as mean ± SD.

1h IP
ratio

p

24h IP
ratio

p

0.90 ± 0.35

0.6892 0.70 ± 0.17

0.0025

0.92 ± 0.12

0.3174 1.33 ± 0.01

0.000

1.06 ± 0.12

0.4066 1.04 ± 0.15

0.6672

1.01 ± 0.0.1

0.8886 1.28 ± 0.01

0.000

0.85 ± 0.08
1.07 ± 0.06
1.03 ± 0.07
1.09 ± 0.53
0.90 ± 0.05
1.02 ± 0.15

0.0016
0.0818
0.5092
0.3222
0.0002
0.8886

0.94 ± 0.24
0.87 ± 0.25
1.37 ± 0.36
1.20 ± 0.04
1.22 ± 0.36
1.39 ± 0.10

0.6672
0.3734
0.0718
0.000
0.2938
0.000

0.97 ± 0.13

0.7434 1.14 ± 0.45

0.5824

1.05 ± 0.14
0.76 ± 0.05
0.84 ± 0.06

0.6384 1.36 ± 0.19
0.000 0.99 ± 0.33
0.000 1.24 ± 0.15

0.0088
0.9442
0.0258

0.98 ± 0.11

0.8026 1.13 ± 0.16

0.2380

0.86 ± 0.07
0.90 ± 0.04
0.80 ± 0.11
1.03 ± 0.1

0.0008
0.000
0.0124
0.603

0.9680
0.000
0.9522
0.0384
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1.14 ± 0.20
1.06 ± 0.02
1.01 ± 0.12
1.27 ± 0.18

Table 3. 13. Hippocampal mitochondrial proteins
protein
NADH-ubiquinone
oxidoreductase B18 subunit
Ubiquinol-cytochrome-c
reductase core protein 2
Cytochrome c1, heme protein
Ubiquinol-cytochrome c
reductase 11 kDa protein
ATP synthase gamma chain
ATP synthase subunit alpha
Aspartate aminotransferase
Glutamate dehydrogenase 1
Malate dehydrogenase
Citrate synthase
Isocitrate dehydrogenase subunit
α
Dihydrolipoyl dehydrogenase
Hexokinase-1
ADP\ATP translocase ANT1
Mitochondrial precursor proteins
import receptor (TOM70)
Aralar1
VDAC1
VDAC3
60 kDa heat shock protein
Data were expressed as mean ± SD.

1h CON
ratio

p

24h CON
ratio
p

0.97 ± 0.16

0.7872 1.26 ± 0.14

0.0012

1.19 ± 0.28

0.3422 1.34 ± 0.69

0.4902

1.02 ± 0.11

0.7872 1.26 ± 0.17

0.0078

1.07 ± 0.20

0.5156 1.54 ± 0.83

0.2584

0.96 ± 0.05
0.87 ± 0.02
0.99 ± 0.06
0.95 ± 0.07
0.95 ± 0.06
1.12 ± 0.18

0.1646
0.000
0.8572
0.215
0.1556
0.3576

1.28 ± 0.12
1.23 ± 0.28
1.64 ± 0.30
1.12 ± 0.14
1.48 ± 0.25
1.60 ± 0.45

0.000
0.147
0.0002
0.2802
0.0008
0.0602

1.14 ± 0.05

0.000

1.37 ± 0.15

0.000

1.08 ± 0.29
0.97 ± 0.01
1.04 ± 0.11

0.6528 1.81 ± 1.28
0.000 1.27 ± 0.22
0.5418 1.65 ± 0.33

0.2758
0.034
0.0006

1.28 ± 0.06

0.000

1.17 ± 0.30

0.3222

0.85 ± 0.14
0.99 ± 0.24
1.21 ± 0.15
0.93 ± 0.04

0.0026
0.9602
0.0512
0.0022

1.09 ± 0.06
1.29 ± 0.44
1.51 ± 0.08
1.40 ± 0.16

0.025
0.246
0.000
0.000
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injury. Ubiquinol-cytochrome-c reductase complex core protein 2 was significantly (p =
0.000) increased 33% in IP hippocampus 24 h post injury. Levels of ubiquinolcytochrome C reductase complex 11 kDa protein were increased (28%) significantly (p =
0.000) in IP hippocampus at 24 h post injury. ATP synthase gamma chain, a component
of complex V, significantly decreased (p = 0.0016) in IP hippocampus at 1 h post injury.
It increased (p = 0.000) in CON hippocampus at 24 h post injury. ATP synthase subunit
alpha decreased (13%) significantly (p = 0.000) in CON hippocampus 1 h post injury.
Analysis of TCA cycle proteins show that glutamate dehydrogenase increased
(20%) significantly (p = 0.000) 24 h post injury in IP hippocampus, and isocitrate
dehydrogenase [NAD] subunit alpha increased significantly in CON hippocampus at 1 h
(14%, p = 0.000) and 24 h (37%, p = 0.000) post injury. Citrate synthase significantly
increased 39% (p = 0.000) 24 h post injury in IP hippocampus. Aconitate hydratase
significantly increased 45% (p = 0.002) in CON hippocampus 24 h post injury. Malate
dehydrogenase significantly increased 48% (p = 0.0008) 24 h post injury in CON
hippocampus and deceased 10% (p = 0.0002) in IP hippocampus 1 h post injury.
Dihydrolipoyl (dihydrolipoamide) dehydrogenase, a component of the glycine cleavage
system as well as of the alpha-ketoacid dehydrogenase complexes, increased 36% as a
trend (p = 0.0088) in IP hippocampus 24 h post injury. Aspartate aminotransferase,
another enzyme thought to be expressed in liver and heart, was identified in the
mitochondrial sample, and increased significantly (p = 0.0002) in CON (64%)
hippocampus 24 h post injury. This enzyme is also involved in metabolism by catalyzing
oxaloacete related reaction.
Our study also identified proteins involved in glycolysis, protein transport and
folding, and the mitochondrial transition pore (MTP). Hexokinase 1, a member of the
glycolytic pathway and MTP formation, decreased (24%) significantly (p = 0.000) in IP
hippocampus 1 h post injury, and increased (27%) as a trend (p = 0.034) in CON
hippocampus 24 h post injury. A carrier protein, ANT1, increased 24% (p = 0.0258) in IP
hippocampus and 65% (p = 0.0006) in CON hippocampus 24 h post injury, and decreased
significantly (p = 0.000) in IP hippocampus 1 h post injury. Aralar 1 decreased
significantly at 1 h post injury in IP(p = 0.0008) and CON (p = 0.0026) hippocampus.
Mitochondrial precursor protein importer receptor TOM70 increased significantly (p =
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0.000) 1 h post injury in CON hippocampus. VDAC1 and VDAC3 are involved in outer
membrane permeability. Our data showed that VDAC1 significantly decreased 10% (p =
0.000) in IP hippocampus 1 h post injury but increased (6%) significantly in IP
hippocampus 24 h post injury. VDAC3 decreased (20%) as a trend (p = 0.0124) 1 h post
injury in IP hippocampus, but increased significantly (p = 0.000) in CON hippocampus
24 h (51%) post injury. Heat shock protein, HSP60, increased in IP (27%) as a trend (p =
0.0384) and significantly increased (p = 0.000) in CON (40%) hippocampus 24 h post
injury.
3.3.4 Validation of VDAC and Hexokinase 1 with Western Blot Analyses
Proteomic analysis identified proteins with expression changes following TBI. In
order to validate proteomic identification, VDAC and hexokinase 1 protein expressions
were quantified by Western blot analysis. Our data showed that VDAC expression
significantly (p < 0.05) decreased in IP cortex 24 h post injury, with 20% decrease
compared to sham animals (Figure 3.14). HK1 expression also significantly (p < 0.05)
decreased in IP cortex compared to sham (Figure 3.15). The ratio of protein expression
from Western blot is comparable to those observed from proteomics using ICAT labeling
and 2D LC/MS/MS. As the three independent samples were used in western blot, our
data indicate the proteomics method using pooled samples is effective to determine
proteins with prominent changes following TBI.
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Figure 3.14. Western blot analysis of VDAC protein levels in IP cortex (panel A) and
CON cortex (panel C). There is a significant (p < 0.05) time dependent decrease in
VDAC in IP cortex (panel B), but no significant change in CON cortex (panel D).
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HK1 expression
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HK1 expression
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Figure 3.15. Western blot analysis of hexokinase in IP cortex (panel A) and CON cortex
(panel C). There is a statistically significant (p < 0.05) time dependent decrease in HK1
levels in IP cortex compared to sham cortex (panel B). There were no significant
differences in HK1 in CON cortex (panel D).
Copyright © Changxing Shao 2007

93

Chapter Four
Discussion
4.1 Reduced Tissue Sparing in TBI in Aging
Aging is associated with increased mortality rates and neurological deficits
following TBI, but the mechanism is not well understood (Teasdale et al., 1979; Hamm et
al., 1991; Hamm et al., 1992; Klein et al., 1996; Maughan et al., 2000; Hoane et al.,
2004). Previous studies show traumatic brain injury results in delayed dysfunction and
death of neuron populations near and distant to the site of injury through secondary
processes (Cooper, 1985). Neuron death can lead to tissue shrinkage or loss. In an aging
study, Hoane et al. (Hoane et al., 2004) showed that middle aged animals suffered more
tissue loss than young animals after TBI, although aged animals were not investigated in
their study. The current data described in this dissertation show middle aged and aged
animals both experience significant tissue loss compared to young animals with no
significant difference between middle aged and aged animals 7 days post injury. More
brain tissue loss indicates more severe damage to the brain, and could lead to more
problems following injury. So the current result may explain why aged animals have
increased mortality rate than young adult animals, but does not provide insight into the
differences between middle-aged and aged animals. To further investigate effects of age
in TBI, further studies are required to evaluate the changes of brain in aging in TBI.
4.2 Oxidative Stress in Head Trauma in Aging
Oxidative damage is suggested to be an important factor for neurological deficits
(Camandola et al., 2000; Anderson et al., 2005; Hall et al., 2005) following TBI, and is
also hypothesized to play a role in diminished recovery from TBI in aged subjects. The
oxidative damage is initiated by increased ROS in cell. There are several sources for ROS
in cell, and mitochondria are believed to be major source following TBI. ROS can cause
oxidative damage to biological macromolecules, including peroxidation of membrane
polyunsaturated fatty acids (PUFA) (McCall et al., 1987; Beckman et al., 1993; Hall et
al., 2004) and DNA (Johnson et al., 2005; Wang et al., 2005). PUFA peroxidation
ultimately leads to loss of both structural and functional integrity of the cell with
generation of toxic aldehydic by-products, such as HNE and acrolein (Uchida and
Stadtman, 1994), which may further contribute to neuronal cell death by protein and
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DNA modification (Graham et al., 1978). DNA oxidation and modification by aldehydes
may lead to gene mutation and affect transcription (Barzilai and Yamamoto, 2004;
Shimamura et al., 2004).
In the current study, in order to look at changes in cortex and hippocampus in TBI
in aging except for tissue loss, the markers of oxidative damage, HNE, acrolein, and
oxidized DNA bases, were investigated at 24 h or 7 days post injury. The oxidative
damage 24 h post injury could show changes in neurons before cell death, and the
damage at 7 days post injury could show the neuron damage even it survived at this time
point. So the study at this two time point provided an early and late response of neuronal
cell in cortex and hippocampus to TBI.
4.2.1 Lipid Peroxidation in TBI in Aging
There have been few studies of markers of oxidative stress or antioxidant
capacities following TBI in aged animals (Wagner et al., 2004). The present study
demonstrates age dependent increased lipid peroxidation 1 and 7 days following TBI. To
minimize biological variation among animals, CON tissues of injured animals were used
as control to investigate the changes in IP tissues. The data described in this dissertation
show there were no significant differences in HNE or acrolein levels between CON
tissues of injured animals and CON and IP tissues of sham animals. Previous studies also
show distal tissues in CCI model showed no significant response in oxidative damage
(DeKosky et al., 2004). In comparison of levels of lipid peroxidation in tissues isolated
before and after in skull flash-freezing showed no artifactual oxidation occurring during
the time between cervical dislocation and tissue extraction.
In cortical TBI, the hippocampus suffers significant neuronal loss immediately
after injury that increases for up to seven days post injury, which may contribute to
memory deficit. Using immunohistochemistry Wang et al. (Wang et al., 2003) showed
HNE levels increased following TBI in IP hippocampus in young animals. Using dot blot
immunochemistry, we showed HNE levels increased significantly in IP hippocampus 24
h post injury in each age group, suggesting pronounced lipid peroxidation and protein
modification at this time point. The intensive oxidative damage could lead to delayed
neuron death in IP hippocampus. Acrolein, another neurotoxic marker of lipid
peroxidation, showed a similar trend as HNE with aged animals showing higher levels in
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IP hippocampus compared to CON hippocampus. At 7 days post injury, levels of HNE
and acrolein in IP hippocampus were reduced to CON hippocampal levels in young
animals. This phenomenon may indicated young animals are able to reduce oxidative
damage by its own defense. Although middle aged animals also showed reduced levels of
HNE and acrolein compared to 24 h post injury, the levels were elevated compared to
contralateral hippocampus. Levels of HNE remained elevated in aged animals at 7 days
post injury. The increased oxidative damage following TBI could lead to mitochondrial
dysfunction (Lifshitz et al., 2003) and diminished neuron recovery following TBI. The
age dependent oxidative damage in hippocampus may help explain increased functional
deficit following TBI in aged subjects.
In cortex, primary mechanical brain injury causes subdural hematoma, laceration,
diffuse vascular injury, and cell death in the impact zone that involves extensively
complicated processes (BIROS, 1998b; Raghupathi, 2004). ROS generation in cortex of
young animals following TBI increases with time in early stages (Hall et al., 1993; Smith
et al., 1994; Nishio et al., 1997). In addition, documented studies show lipid peroxidation
products significantly increase immediately following injury, and remain elevated for
several days in young animals (Hall et al., 2004). HNE levels increased in IP cortex in
each age group at 24 h post injury, but did not show age dependent differences. At 7 days
post injury, HNE levels decreased in IP cortex in young animals, but kept increasing in
middle aged animals. Aged animals did not show more oxidative damage 7 days post
injury compared to 24 h post injury. Unlike oxidative damage in hippocampus, there is no
clear age dependent change in cortical lipid peroxidation, especially at 24 h post injury.
Hall et al. (1993) reported that a major source of ROS is microvasculature, and saline
perfusion of the injured mice eliminated ROS levels measured in their study (Hall et al.,
1993). Blood is enriched by iron from hemoglobin. The free iron catalyzes the formation
of ROS by Fenton’s reaction and could lead to increase of lipid peroxidation. The cortex
samples harvested following TBI were bloody in the current study, so it is possible that
blood in the cortex tissues led to significant lipid peroxidation and masked the difference
in lipid peroxidation in aging in our study.
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4.2.2 DNA Oxidation in TBI in Aging
As discussed above, oxidative stress plays a pivotal role in TBI in aging.
Mitochondria are major sources of superoxide radicals especially following
mitochondrial dysfunction (Xiong et al., 1997b; Sullivan et al., 2002; Lifshitz et al.,
2003). Superoxide can be converted to hydrogen peroxide by superoxide dismutase
(SOD) (Fridovich, 1997). Hydrogen peroxide is further transformed to water through
glutathione peroxidase. However, it can potentially interact with transition metals to form
hydroxyl radicals that are significantly increased following TBI (Smith et al., 1994).
Hydroxyl radicals can attack nucleic acids, and lead to oxidative damage (Rehman et al.,
1999). More than 20 oxidized DNA bases have been identified (Candeias and Steenken,
2000; Evans et al., 2004), of these 8-hydroxyguanine is the most studied because it is the
predominant marker of DNA damage (Pratviel and Meunier, 2006). Fapyguanine, 8hydroxyadenine, fapyadenine, and 5-hydroxycytosine are other products of guanine,
adenine and cytosine oxidative damage. In order to further evaluate oxidative damage in
TBI in aging, we quantified five DNA base oxidation products to quantify the different
oxidative response in aging. For this study, GC/MS-SIM was used because it can monitor
multiple bases simultaneously in a single run (Dizdaroglu, 1990).
Previous studies showed increased 8-hydroxyguanine (8-OHG) levels in rat
cortex 15 min post injury using immunohistochemistry (Mendez et al., 2004) in young
animals. Our present study using GC/MS-SIM showed 8-OHG levels were increased as a
trend but not statistically significant in IP cortex of injured and sham animals compared
with their CON cortex. No significant differences were observed between injured and
sham animals 24 h post injury. Additionally, no significant differences were observed in
8-OHG levels in middle aged IP or CON cortex between injured and sham animals. In
contrast, aged animals showed 8-OHG levels significantly increased in IP cortex of
injured animals compared with their CON cortex and with sham animals. Moreover, 8OHG levels were significantly higher in IP cortex of aged animals compared to young
and middle aged animals, suggesting an age dependent increase of oxidative damage. Our
lipid peroxidation study in TBI in aging showed lipid peroxidation was significantly
increased in young, middle aged and aged animals in cortex 24 h post injury (Shao et al.,
2006). The differences in lipid peroxidation and DNA damage in young and middle aged
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animals suggest lipid damage increases more rapidly than DNA damage. In aged animals,
severe oxidative damage can lead to both DNA and lipid oxidation. In hippocampus,
extensive DNA damage was observed even though it is subjected to less mechanical
injury compared to cortex. Our data suggest an age dependent increase of DNA damage
with significant elevations of 8-OHG in injured IP hippocampus of middle aged and aged
animals compared with young animals. In addition, 8-OHG levels in IP hippocampus in
middle aged and aged animals were significantly increased compared to CON
hippocampi. These data are consistent with our previous study of lipid peroxidation in
TBI in aging (Shao et al., 2006). The presence of increased levels of DNA base adducts
and lipid peroxidation byproducts in aged animals may help explain why aged animals
exhibit increased neuron and memory loss following TBI (Ward et al., 1999). DNA
damage may be particularly problematic because it can lead to alterations in transcription
through a G:C to T:A mutation (Barzilai and Yamamoto, 2004), and changes in gene
expression (Shimamura et al., 2004). Although DNA repair in nuclei can be mediated by
MutT homolog (MTH1), MutT or oxoguanine glycosylase (OGG1) (Nakabeppu et al.,
2004), extensive ROS may overwhelm the repair capacity. Although fapyguanine, 8hydroxyadenine, fapyadenine, and 5-hydroxycytosine levels were not significantly
different in aging in TBI, there was a trend toward increased levels of these oxidized
bases in aging.
4.2.3 Antioxidant Enzyme Activities in TBI in Aging
Previous studies that secondary oxidative damage can regulate gene expression
and inflammatory response in the hippocampus, especially in genes related to metabolism
and antioxidant enzymes (Long et al., 2003). However, proteins are the units that
function directly in cell defense, and gene transcription change may not necessarily
reflect antioxidant enzyme defense capacity since oxidative damage may inactivate
enzymes following TBI. In order to quantify cellular defense capacities, protein activity
is most direct measure for the study. There are several antioxidant enzymes in neurons
that decrease oxidative stress, including Cu/ZnSOD, MnSOD, catalase, GPx, GSSG-R,
and GST. Although these enzymes work in concert to protect the cell, cell death can
result if ROS production exceeds the defense capacity. We hypothesize that oxidative
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damage, lipid peroxidation and DNA oxidation, following TBI and the differences in
oxidative damage in TBI in aging may result from deficits in antioxidant capacities.
Superoxide dismutases function to convert superoxide ion to less active hydrogen
peroxide and avoid the formation of further ROS, and have been widely investigated in
neurodegenerative diseases. Transgenic mice overexpressing SOD showed increased
tissue sparing and improved neurological function compared with their WT littermates
following TBI (Maier and Chan, 2002). In addition, Dekosky et al (DeKosky et al., 2004)
reported that SOD activity decreased significantly 6 h after TBI and 20% of activity was
lost 24 h and 30% lost 7 days post injury in young rats subjected to severe injury in the
anterior hippocampus. Our data failed to show a significant age-dependent change in
Cu/ZnSOD activity for any age or time point studied. Although MnSOD does not change
significantly in young and middle aged animals 24 h post injury, it decreased
significantly (20%) in aged animals compared to middle aged animals. In contrast to the
study of Dekosky et al. (DeKosky et al., 2004), we did not observe significant losses of
SOD even 7 days post injury in young animals. However, we observed a 30% loss in IP
hippocampus MnSOD activity in middle aged and aged animals. Statistical analysis
showed an age-dependent decrease of MnSOD activity in aging. The decrease of the
mitochondrial MnSOD could compromise the cell’s ability to remove superoxide
generated after the TBI and lead to mitochondrial damage (Xiong et al., 2005), increased
lipid peroxidation (Awasthi et al., 1997), and DNA damage, which could lead to cell
apoptosis and result in neuron loss and cognitive deficits in older animals.
In the antioxidant defense system, glutathione peroxidase follows SOD and
reduces hydrogen peroxide to water with consumption of glutathione. Table 2 shows that
GPx increased in young IP hippocampus 1 and 7 days post injury with little change in
middle aged or aged animals. The current data in this dissertation show a significant age
dependent decrease of GPx activity observed 24 h post injury in middle aged and aged
animals compared to young animals. At 7 days post injury, GPx activities were lower in
middle aged and aged IP hippocampus compared with young IP hippocampus, although
the differences did not reach statistical significance. These data are consistent with those
of Dekosky et al. (DeKosky et al., 2004) who showed increased GPx activity in
hippocampus in young TBI animals 7 days post injury. Our data further show that GPx
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protein expression increased significantly (data not shown) in IP cortex and
hippocampus, which is consistent with the theory that this enzyme is upregulated by
oxidative stress (Baud et al., 2004). However, higher abundance of this enzyme did not
improve neuron antioxidant capacity in middle aged and aged animals. Young animals
showed elevated GPx activities compared with older animals that may help limit further
oxidative damage.
Previous studies show GST overexpression is neuroprotective in cell culture (Xie
et al., 2001). Glutathione transferase can alleviate damage from lipid peroxidation byproducts (HNE and acrolein) by catalyzing their conjugation with glutathione (GSH).
GST depletion could result in increased protein modification and lead to more protein
dysfunction, which could contribute to further oxidative damage. Our data show
significant GST activity loss in IP hippocampus 7 days post injury for middle aged and
aged animals, but not for young animals. However, there is no significant difference in
aging in IP hippocampus. Glutathione reductase, which functions to regenerate reduced
glutathione, has been studied in neurodegenerative disease (Lovell et al., 1995), but not in
traumatic brain injury. Our study shows a significant decrease in GSSR-R in middle aged
and aged IP hippocampi at 7 days post injury, but not for young animals.
Antioxidant enzyme activities have not been studied in cortex in TBI even though
oxidative stress has been well documented in the last several decades. Our data show
MnSOD in IP cortex was depleted in an age dependent manner 24 h post injury and that
the decrease correlated with increased tissue loss. Diminished antioxidant activity may
compromise defense capacities against oxidative stress (Azbill et al., 1997), and may
contribute to neuron death in the impact zone. At 7 days post injury, MnSOD activity in
IP cortex significantly decreased in young, middle aged and aged animals, but did not
show an age dependent difference. Activities of Cu/ZnSOD were decreased in IP cortex
of all three age groups 7 days post injury, but they did not show significant age dependent
differences. GPx activity did not change significantly 24 h post injury in any age group
studied, although young and middle aged animals showed increased activity as a trend at
7 days post injury. There were no age dependent differences at any time point for this
antioxidant enzyme. GST activity decreased 24 h post injury in IP cortex in each age
group with more pronounced decreases occurring in middle aged animals 7 days post
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injury. GST depletion in cortex may result in intensive biochemical modification of
biomolecules by toxic aldehydic byproducts from lipid peroxidation, suggesting middle
aged animals may suffer further damage. GSSG-R decreased significantly in middle aged
and aged IP cortex compared to young animals 24 h post injury, although no significant
differences were observed 7 days post injury. GSSR-R depletion 24 h post injury could
contribute to depletion of glutathione, a critical low molecular weight (LMW)
antioxidant, and contribute to cell death and tissue loss in later days.
4.3 Mitochondrial Proteomics in TBI
In TBI, there was significant tissue loss in injured cortex 1 week post injury, but
not at 24 hours post injury. However, there is significant oxidative damage at 24 h post
injury, showing increased HNE, acrolein, and oxidized DNA bases. The oxidative
damage in neuron is closely connected with mitochondria because mitochondria are the
major source of ROS. In order to examine changes of mitochondria before the tissue loss,
we examined changes of mitochondrial protein expression in cortex 1 h and 24 h post
injury. Additionally, hippocampal mitochondrial protein levels were also evaluated at the
same time points.
4.3.1 Mitochondrial Proteomics of Cortex
Previous studies show that ATP depletion, increased oxidative stress, cytochrome
c release, and compromised mitochondrial function follow TBI (Xiong et al., 1997b;
Sullivan et al., 1998; Lewen et al., 2001; Lifshitz et al., 2004). Lifshitz et al. showed
significant morphologic and integrity damage, and reduced mitochondrial proteins
isolated from mitochondria in injured cortex and hippocampus at 3 h and 24 h post injury
using a fluid-percussion model (Lifshitz et al., 2003; Lifshitz et al., 2004). Mitochondrial
dysfunction involves multiple proteins, which indicates a very complicated process
(Nicholls and Budd, 2000). Although reduced mitochondrial protein was isolated from
brain tissues of animals following TBI, individual mitochondrial protein expression
levels in isolated mitochondria were not investigated. Mitochondrial proteomics could
investigate multiple proteins involved in the dysfunction. In the present study,
mitochondrial protein expression in IP and CON tissues of animals subjected to TBI was
quantified relative to animals subjected to sham surgery. The majority (75.7%) of the
proteins identified were mitochondrial according to the Swiss-Prot database, and included
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proteins involved in energy metabolism, small molecule transport, and mitochondrial
outer membrane permeability.
Respiratory chain damage is widely investigated in other neurodegenerative
diseases, including Huntington’s disease, ALS, AD, Parkinson’s disease, and ischemia
(Fiskum et al., 1999). Damage to the respiratory chain following TBI is supported by
studies of mitochondrial respiration in TBI, that show damage to state 3 (Vink et al.,
1990; Xiong et al., 1997a; Sullivan et al., 2005). In our study, we show levels of some
subunits of complex III, and IV were significantly reduced 24 h post injury. Complex III,
also known as the cytochrome bc1, oxidize ubiquinol (ubihydroquinone) which reacts in
one membrane phase, reduces cytochrome c in the intermembrane space (or periplasm in
bacteria), and use the free energy change to drive H+/QH2 across the membrane from the
matrix to the inner membrane space. It is suggested that this complex is one of the major
sites for electron leakage. Mitochondrial cytochrome c-1 is a collapsed di-heme
cytochrome (Baymann et al., 2004), that was not changed 1 h post injury in IP cortex, but
was increased in CON cortex, and reduced in IP cortex 24 h post injury. Ubiquinolcytochrome-c reductase complex core protein 2 was not changed 1 h post injury in IP, but
was increased in CON cortex. Levels of the protein were decreased in both IP and CON
cortices 24 h post injury. The decrease of the two complex III subunits could lead to
significant electron leakage and oxidative damage to cell. Complex IV (cytochrome
oxidase complex) is the site that oxygen binds with protons to form water, with the
formation of a proton gradient. There are three main subunits and ten small subunits for
complex IV. Among the small subunits, the subunits cox5b is small globular proteins
bound to the matrix side of the core, and the globular subunit cox6b1 faces the
intermembrane space (Michel et al., 1998). Subunit cox6b1 binds a zinc ion of unknown
function in a tetrahedral coordination. It is suggested that the small subunits act as
regulators and bind effectors and are required for complex assembly (Kadenbach, 1986).
A previous study showed reduced cytochrome oxidase activity followed TBI (Hovda et
al., 1991). Our data show cox5b (cytochrome c oxidase polypeptide Vb) levels decreased
significantly 24 h post injury in both IP and CON cortices, but were not changed 1 h post
injury in IP or CON cortex. In spinobulbar muscular atrophy disease, it has been shown
that sequestration of cox5b by human androgen receptor (hAR) leads to mitochondrial
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dysfunction (Beauchemin et al., 2001). In cancer cells, cox5b up-regulation increases
retention of cytochrome c and enhances synthesis of ATP (Wu et al., 2000; Wu et al.,
2003). So the decrease of cox5b expression after TBI in both IP and CON cortex may
lead to mitochondrial dysfunction and reduced ATP production. The difference of this
polypeptide levels between 1 and 24 h post injury indicates a time dependent change. In
addition, another subunit of complex IV, cox6b1 (cytochrome c oxidase polypeptide
VIb), decreased 24 h post injury in IP cortex. The compromised subunits of complex I,
III and IV could lead to respiration deficiency that could lead to secondary respiratory
deficiencies (Rotig et al., 2004) that . The respiratory deficiency could lead to significant
electron leakage, and perturb proton transport and proton gradient. The proton gradient is
the driving force for ATP production by complex V.
The TCA cycle involves multiple enzymes and is a key process for ATP
production in mitochondria. Our data show dihydrolipoyl dehydrogenase and alphaketoglutarate dehydrogenase are decreased significantly 24 h post injury in IP cortex, but
not in CON cortex at this time point and IP and CON cortex 1 h post injury.
Dihydrolipoyl dehydrogenase is a common component in three α-keto acid
dehydrogenase complexes, including pyruvate, α-ketoglutarate and branched-chain αketo acid dehydrogenase complexes (Reed, 1974). This enzyme catalyzes the reoxidation
of the dihydrolipoyl prosthetic group attached to the lysyl residue(s) of the
acyltransferase components of the three α-keto acid dehydrogenase complexes.
Reoxidation of the dihydrolipoyl group generates FADH, which can reduce NAD+ to
NADH. Alpha-ketoglutarate dehydrogenase is a component of the alpha-ketoglutarate
dehydrogenase complex, along with dihydrolipoamide succinyltransferase (E2) and
lipoamide dehydrogenase (E3). This complex catalyzes the overall conversion of alphaketoglutarate to succinyl-CoA and CO2 with production of NADH. Decreased levels of
proteins could compromise the TCA cycle and production of NADH, which could lead to
ATP depletion in tissues following TBI. Previous studies show alpha-ketoglutarate
dehydrogenase complex deficiencies lead to cytochrome c release (Huang et al., 2003). It
was also shown this enzyme was mediator of oxidative stress and mitochondrial
dysfunction (Gibson et al., 2005). So the decrease of alpha-ketoglutarate dehydrogenase
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could lead to deficiency of the enzyme complex and lead to mitochondrial dysfunction,
cell apoptosis and neuron degeneration.
Creatine kinase, an enzyme involved in energy transport is also a component of
the MTP (Brdiczka et al., 1994). Our data show this enzyme was increased in CON
cortex 1 h post injury, which suggests a compensatory response of cells to generate more
ATP at this time point. Hexokinase 1 (HK1) and glyceraldehydes-3-phosphate
dehydrogenase (GPDH) are key enzymes of cellular glycolysis, and are closely
associated with mitochondria. HK1 is suggested to promote VDAC channel closure and
prevent mitochondria mediated apoptotic cell death by inhibiting cytochrome c release
(Azoulay-Zohar et al., 2004; da-Silva et al., 2004). HK1 may affect ATP production by
affecting the supply of ADP (Birnbaum, 2004). Previous studies shows enhancement of
glycolysis with a Pasteur effect, a shift from slow aerobic to rapid anaerobic consumption
of glucose, after respiratory inhibition (Kauppinen and Nicholls, 1986). Our Western blot
analyses showed increased HK1 expression following injury (data not show), which may
show the Pasteur effect. However, the mitochondria-bound HK1 decreased significantly
at 24 h post injury. The decrease of mitochondria-bound HK1 could lead to outer
membrane permeability changes and cytochrome c release 24 h post injury in IP cortex.
GPDH was thought to be a housekeeping protein, and regulate apoptosis by the
inactivation of cytoprotective heat shock protein 70 (HSP70) in neurodegenerative
disease and aging (Ishitani et al., 1996; Kragten et al., 1998; Chuang et al., 2005). It has
been shown that more GPDH was deposited on mitochondria in cells undergoing
apoptosis than cells under normal conditions (Saunders et al., 1997). Our data show
GPDH levels in IP cortex increased as a trend at 24 h post injury. The increased GPDH
may contribute to cell apoptosis and neuron dysfunction. Another key protein in
apoptosis, VDAC, was shown decreased significantly in IP cortex 24 h post injury.
Western blot analysis shows the same result as ICAT proteomics. VDAC is a key protein
regulator of outer membrane permeability, which permits influx or efflux of molecules ≤
1500 Da. In addition, VDAC is a also key component of the MTP formed under stress,
other members including ANT in the inner membrane, cyclophilin D (CypD) in the
matrix, creatine kinase in intermembrane space, and hexokinase in the outer membrane
(Verrier et al., 2003). Our data show VDAC (1 & 3) levels decreased significantly in IP
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cortex 24 h post injury, but not 1 h post injury. VDAC plays a key role in exchange of
metabolites and metal ions between mitochondria and cytoplasm (Rostovtseva et al.,
2005). The protein decrease may lead to decreased permeability resulting in slower
response to calcium (Lifshitz et al., 2003). Our study identified ADP/ATP carrier protein
(ANT 1), and showed a significant increase 1 h post injury, which may indicate a
compensatory response to injury. Buck et al. showed increased ANT1 facilitated
glutamate transport (Buck et al., 2003). The ANT1 level increase 1 h post injury in IP
cortex and may indicate the neurons’ response to reduce the excess glutamate released
following TBI.
Carrier proteins play an important role in mitochondrial function. Cytosolic
NADH is transported into mitochondria for oxidative metabolism and ATP production
through two NADH shuttles, including the malate/aspartate shuttle (LaNoue and
Schoolwerth, 1979). The shuttle requires aspartate/glutamate carrier, which has two
isoforms (aralar 1 and citrin) (Brown, 1992). The overall structure of citrin is similar to
that of aralar 1, and both have four EF-hand Ca2+ -binding motifs in their N-terminal
domains (del Arco and Satrustegui, 1998). Previous studies show recombinant expression
of aralar 1 and citrin increased ATP production by stimulation of Ca2+-mobilizing
agonists, in which aralar 1 and citrin function to decode calcium signals from cytosol for
mitochondria (Palmieri et al., 2001; Lasorsa et al., 2003). It was also shown that aralar
knock-out mice are growth-retarded, exhibited generalized tremoring, and had
pronounced motor coordination defects along with an impaired myelination in the central
nervous system (Jalil et al., 2005). Our data show calcium-binding mitochondrial carrier
protein aralar 1 and mitochondrial glutamate carrier 1 (citrin) expression levels decreased
as a trend in IP cortex 24 h post injury. The compromised protein expression could
decrease NADH transport, ATP synthesis, and myelin lipid synthesis. However, the two
proteins showed increased levels in CON cortex 1 h post injury, which could increase
ATP production in CON cortex at this time point.
Mitochondria are dynamic organelles, and their fission and fusion could produce
new mitochondria or repair damaged mitochondria. Lifshitz et al. (2003) showed that
reduced mitochondrial proteins isolated following TBI in cortex. Our data showed even
in intact mitochondria or slightly damaged mitochondria, protein or polypeptide levels
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related to energy metabolism, transport, and mitochondrial transition pore are decreased.
Lower levels of key mitochondrial proteins could lead to mitochondrial dysfunction and
significant oxidative stress, which could reduce mitochondrial protein yield (Cahill et al.,
1997).
4.3.2 Mitochondrial Proteomics of Hippocampus
Our proteomics study of cortical mitochondria following TBI showed significant
changes in proteins involved in the respiratory chain, TCA cycle and the MTP 24 h post
injury, especially in IP cortex. In cortical TBI, hippocampus receives less mechanical
injury although secondary injury was demonstrated. Mitochondrial damage was evident
24 h post injury, as demonstrated by disrupted cristae, thinned outer membrane and
ballooned appearance, and ATP depletion in CA3, but not CA1. In order to evaluate
changes in mitochondrial protein levels in TBI, ICAT proteomics was carried out as
described above. Twenty-nine proteins were identified in both IP and CON hippocampi
at 1 and 24 h post injury, and 20 proteins showed significant changes. The proteins
identified included proteins involved in energy metabolism, small molecule transport, and
the MTP.
Previous

studies

showed

mitochondrial

respiration

was

suppressed

in

hippocampus following TBI (Lifshitz et al., 2003) resulting in decreased ATP production.
Complex I is one of the major electron entry points for the electron transport chain, and
the largest and most complicated respiratory complex consisting of at least 46 subunits
(Fearnley et al., 2001). Complex I defects are associated with neurodegenerative diseases
and aging (Lenaz et al., 1997; Schapira, 1998). NADH-ubiquinone oxidoreductase B18
subunit (NADH dehydrogenase [ubiquinone] 1 beta subunit 7), which functions to
transfer electrons from NADH to ubiquinone with the generation of a proton gradient, is
significantly decreased 24 h post injury in IP hippocampus, but increased in CON
hippocampus. At 1 h post injury, this protein is maintained in IP and CON hippocampus.
The decrease of NADH-ubiquinone oxidoreductase B18 subunit could lead to complex I
dysfunction. In Complex III, our data show several protein subunits, including ubiquinolcytochrome-c reductase complex core protein 2 and ubiquinol-cytochrome C reductase
complex 11 kDa protein, increased significantly 24 h post injury in IP hippocampus,
although no significant changes were observed at 1 h. These changes show a different
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response compared with cortical mitochondria. The increase of protein expression could
improve the availability of these polypeptides in complex assembly and improve
mitochondrial function. As for complex V, ATP synthase gamma chain increased in CON
hippocampus 24 h post injury. The increase of protein expression 24 h post injury may
indicate a compensatory response of cells to injury. Although ATP synthase gamma
chain and ATP synthase subunit alpha decreased 1 h post injury in IP or CON
hippocampus, the change is very small.
The TCA cycle involves multiple enzymes and is a key process for ATP
production in mitochondria. Citrate synthase, dihydrolipoyl (dihydrolipoamide)
dehydrogenase, and glutamate dehydrogenase were significantly increased in IP
hippocampus 24 h post injury. Citrate synthase is the first enzyme that controls the
entrance of carbon into the TCA cycle (Krishnan et al., 2003). The increase of this
enzyme may suggest upregulation of the TCA cycle in an effort to speed up energy
metabolism. Increases of dihydrolipoyl dehydrogenase could lead to increased NADH
production in IP hippocampus. Aconitate hydratase and malate dehydrogenase increased
in CON hippocampus 24 h post injury. Increased aconitate hydratase could show
increased TCA energy metabolism in CON hippocampus 24 h post injury. Isocitrate
dehydrogenase [NAD] subunit alpha increased 1 h and 24 h post injury in CON
hippocampus. Increases of malate dehydrogenate and isocitrate dehydrogenase [NAD]
subunit could increase NADH production. Aspartate aminotransferase, another enzyme
identified in this study is thought to be expressed in liver and heart, was shown increased
levels at 24 h post injury in brain hippocampus. The increase of the protein suggests a
compensatory response of mitochondria, and tries to produce more substances for ATP
production.
Our study also identified proteins involved in glycolysis, protein transport and
folding, and formation of the mitochondrial transition pore (MTP). Hexokinase 1, a
member of the glycolitic pathway and the MTP, was decreased in IP cortex 1 h post
injury. In contrast, it increases to control levels 24 h post injury. Similar trends were
observed in CON hippocampus at this time point. The increase of HK1 could reduce
cytochrome a release and inhibit cell apoptosis. These data suggest the presence of
mitochondrial recovery or repair following TBI. A carrier protein, adenine nucleotide

107

translocator 1 (ANT1), functions to transport ATP and ADP in oxidative phosphorylaion.
Our data show ANT1 levels increase in IP and CON hippocampus 24h post injury, which
suggests increased mitochondrial metabolism at this time point in both IP and CON
tissues. Voltage-dependent anion-selective channel protein 1 (VDAC1) and voltagedependent anion-selective channel protein 3 (VDAC3) are key proteins regulating
permeability of the outer membrane of mitochondria (Rostovtseva et al., 2005). Our data
showed the two protein expression levels decreased slightly in IP hippocampus 1 h post
injury, and maintained in IP hippocampus at 24 h post injury. VDAC3 levels go up in
CON hippocampus at 24 h post injury. The decrease of the proteins may delay response
to calcium in IP hippocampus 1 h post injury. The increase of pore proteins in CON
hippocampus 24 h post injury may increase mitochondrial response to calcium. Heat
shock protein, HSp60, is increased in CON hippocampus 24 h post injury. Previous
studies show HSP60 levels increased in cerebrospinal fluid following TBI (Lai et al.,
2006).
Mitochondrial precursor protein import receptor was shown to be significantly
increased in CON hippocampus 1 h post injury. The increased protein level could
indicate cells are trying to increase uptake of nuclear coded protein levels in
mitochondria, and mitochondrial repair and recover.
Lifshitz et al. showed mitochondrial damage and diminished calcium response in
hippocampus using fluid-percussion injury model (Lifshitz et al., 2003). In cortex, our
data show protein levels related to the respiratory chain, TCA and carrier proteins and
MTP proteins decreased, which agree with the damage described by Lifshitz et al. Our
data from hippocampus show that those proteins in isolated mitochondria increased
following injury. It is interesting to note that the mitochondria in hippocampus showed an
earlier response to TBI than cortex even though it receives less mechanical injury.
However, Lifshitz et al. showed hippocampal mitochondria received less damage than
cortical mitochondria. It is possible that the mitochondrial repair mechanism by
multimitochondrial fusion lead to an increase in levels of some proteins in isolated intact
hippocampal mitochondria (Busch et al., 2006; Chan, 2006). The increased levels of
critical proteins in intact mitochondria may speed up ATP production in cells and
compensate the consequence of some mitochondrial damage.
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Mitochondrial

channel protein levels were maintained and other energy metabolic related enzyme
increased in our study. However, Lifshitz et al. showed reduced CsA-sensitive and CsAinsensitive swelling and deficits of the respiratory chain following fluid-percussion
injury. Our data showed increased oxidative stress in hippocampus following TBI. It is
possible that oxidative damage in mitochondria lead to dysfunction of channel proteins
involved in mitochondrial membrane permeability (Singh et al., 2006).
4.4 Protective Property of Creatine in TBI
The aging study in TBI shows significant oxidative damage. These data suggest
treatment of TBI patients with antioxidants may be helpful in recovery. Creatine is shown
to have antioxidant properties, and also enhance energy storage and stabilization of the
mitochondrial permeability transition pore (MTP) (O'Gorman et al., 1997; Sullivan et al.,
2000; Wyss and Kaddurah-Daouk, 2000). Previous studies show creatine protects against
glutamate, 1-methyl-4-phenylpyridinium (MPP+) and β-amyloid toxicity, and blocks
oxidative damage and inhibits cytochrome c release (Klivenyi et al., 1999; Matthews et
al., 1999; Brewer and Wallimann, 2000; Brustovetsky et al., 2001; Scheff and Dhillon,
2004; Zhu et al., 2004; Bender et al., 2005). The present data suggest creatine reduces
oxidative stress and increases antioxidant enzyme capacities in TBI.
In TBI, the hippocampus undergoes significant neuron degeneration and
significantly increased lipid peroxidation 1 and 7 days post injury. In cortex, primary
mechanical brain injury causes cell death in the impact zone that likely involves
complicated processes such as oxidative stress that are evident 1 and 7 days post injury.
Previous studies show creatine supplementation significantly reduces free fatty acid
levels in TBI and inhibits oxidative injury in animal models of amyotrophic lateral
sclerosis (ASL) (Klivenyi et al., 1999; Scheff and Dhillon, 2004). Our data show levels of
HNE were significantly reduced in IP hippocampus and cortex of creatine treated animals
compared to animals with a regular diet. Previous studies also show creatine
supplementation increased creatine and phosphocreatine (Pcr) stores in brain (Dechent et
al., 1999). Creatine kinase, creatine and phosphocreatine play a key role in energy
buffering and transport, and can help reduce glutamate toxicity and maintain Ca2+
homeostasis, which may block oxidative processes (Hemmer and Wallimann, 1993;
Wallimann and Hemmer, 1994; Bender et al., 2005). In addition, creatine can stimulate
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oxidative phosphorylation and inhibit mitochondrial transition pore opening, which can
increase bioenergetic synthesis and may prevent leakage of ROS from mitochondria
(Wallimann et al., 1992; Kay et al., 2000; Meyer et al., 2006).
Our study shows creatine can improve antioxidant capacities, which can
contribute to reduced oxidative stress. Previous studies show SOD activity decreases
following TBI. The experiments conducted in this study show that Cu/ZnSOD activity
was significantly increased to near CON levels in IP cortex and hippocampus of creatine
treated animals compared with regular diet animals. It is possible that increased
phosphocreatine level in cytosol helps to direct protein repair by such enzymes as HSP70
and disulfide isomerase following injury to maintain the enzyme pool with normal
function and lead to higher enzyme activity (Lu et al., 2001; Hansel et al., 2002; Kregel,
2002). MnSOD was significantly increased to CON levels in IP hippocampus of creatine
treated animals compared with controls, but no significant difference was observed in IP
cortex. The mitochondrial proteomics study showed mitochondria were severely
damaged in cortex, which could result in ATP shortage in the mitochondria for MnSOD
folding and repair. Unfortunately, phosphocreatine in cytosol may not help since the
disruption is primarily mitochondrial. Mitochondria in hippocampus receive less damage,
and ATP production and enzyme repair may be maintained. The increase of SOD
improves the cell’s ability to remove superoxide generated after TBI and reduce lipid
peroxidation. Previous studies show Vitamins C and E reduce oxidative stress and
increase antioxidant capacities (Murugesan et al., 2005). Because creatine can function as
a direct antioxidant (Lawler et al., 2002) it can neutralize ROS and reduce oxidative
damage in a similar fashion as Vitamins E and C.
Glutathione peroxidase reduces hydrogen peroxide to water with consumption of
glutathione. Previous studies show GPx activity increased following TBI since this
enzyme is greatly induced by oxidative stress (DeKosky et al., 2004). Our data show GPx
activity decreased in IP tissues in animals with creatine supplementation compared to
controls. Aging studies show dietary restriction extends life by reducing oxidative stress.
Meanwhile, dietary restriction reduces GPx activity in aging (Baek et al., 1999). Reduced
GPx could be an indicator of less oxidative stress, although diminished activity may
accelerate oxidative damage in IP tissues. Lindenau et al. (Lindenau et al., 1998) reported
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that GPx was localized predominantly in microglia in CNS, and was shown to be
upregulated in microglia and astrocytes, but not in neurons after CNS lesion. Based on
previous studies showing that TBI initiated an inflammatory response and led to neuron
damage (Lu et al., 2005), our data suggest that creatine may inhibit microglia and
astrocyte activation, and GPx expression.
Glutathione transferase can alleviate oxidative damage by catalyzing conjugation
of glutathione (GSH) with nucleophilic lipid peroxidation products, especially aldehydic
by-products (HNE and acrolein). In this study, GST activity increased significantly in IP
hippocampus of animals provided with a 2% creatine diet. GST activities showed a
significant dose dependent increase among the three groups. An increase in GST activity
suggests creatine improves the animal’s capacity to decrease oxidative damage. In
contrast to cortex, GST activity did not change in the hippocampus. Glutathione
reductase, which functions to regenerate reduced glutathione, showed reduced activity
following TBI in our previous study. Our current study shows a significant increase in
GSSG-R in IP cortex of creatine supplemented animals. An increase of GSSG-R activity
suggests the cortex may have a greater capacity to maintain the reductive environment
following TBI compared to control, which can protect cells from damage.
Creatine supplementation significantly reduced lipid peroxidation, especially the
amount of HNE, which is the major products of lipid peroxidation and is believed to be
an important marker in oxidative stress (Esterbauer et al., 1991). Although no statistically
significant differences in acrolein levels were observed in cortex and hippocampus, the
trend showed levels of acrolein were reduced in animals provided a creatine
supplemented diet (Lee et al., 2006). Animals provided creatine supplementation did not
show alterations in oxidative damage or antioxidant capacity in CON cortex or
hippocampus suggesting creatine functions in injury. In addition, 2% creatine
supplementation did not show more protection than 1%, except for GST in IP
hippocampus in present study.
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CHAPTER FIVE
Conclusion
TBI is a major public health concern in industrialized nations primarily due to
motor vehicle accidents. TBI is a tragedy for patients and their families, and costs about
$20 billion for treatment annually in the US. Additionally, improved living conditions
have led to extended longevity of humans, and a significant increase of the number of
people age 65 and over. Elderly subjects 75 years or older, show higher death rates
following brain injury due to motor vehicle accidents or falls.
TBI patients suffer a variety of potential problems because of neuron damage near
and remote from the site of injury. Studies to assess neuronal damage following TBI is
the key to finding effective treatments. Research over the past 30 years suggestes the
pathology of TBI occurs at the cellular and molecular level. Currently, it is widely agreed
that secondary injury is important in neurodegeneration following TBI. Current data
suggest the primary mechanical injury is not treatable, leaving secondary injury as the
best hope for treatment in TBI. Although excess excitatory amino acids, mitochondrial
dysfunction, oxidative damage, adenosine and triphosphate adenine nucleotide depletion,
inflammatory events, ion homeostasis disruption, proteolytic enzymes activation, DNA
damage, and cholinergic receptor dysfunction have been shown to contribute to
secondary injury, the exact mechanism is still unclear. We hypothesize oxidative damage
and compromised antioxidant capacity contribute to neurodegeneration following TBI.
This dissertation described oxidative damage and mitochondrial changes in TBI.
In human TBI, computed tomography can be performed immediately following
injury to evaluate tissue damage by measuring the size of infarct or hemorrhage in the
brain. At the site of mechanical injury, tissue loss or shrinkage is observed following
neuronal death or damage hours, days or weeks post injury. Neurons are the basic unit of
brain, and neuron loss could lead to series of problems for patients even though they
survived. Severity of neuronal loss or damage indicates the more severe injury patients
suffer, and the more problems patients could carry in the future. Unfortunately, neurons
cannot regenerate although current studies are aimed at regeneration of neurons by
transplant.
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The work described in this dissertation is the first to measure tissue sparing
following TBI as a function of age using Fisher-344 rats subjected to a controlled cortical
impact injury. Although human subjects can suffer injury at any area of the brain and
injury is probably more complicated, the animal model used in current study can mimic
pathology in human brain injury. In our study, significant tissue loss was observed 7 days
post injury, and showed an age-dependent increase in aging. This is the first study to
show tissue sparing in TBI in aging using young, middle aged and aged animals. The
increase of tissue loss in aging may lead to more problems for aged animals. These
results suggest the aged brain is more fragile and aged neurons are less durable than
young ones.
However, an interesting question is why the response of aged brain is different
from young brain following TBI. The answer to this question could significantly improve
our understanding of the mechanism of secondary injury in aging and led to improved
treatment of aged patients. This dissertation showed significant lipid peroxidation and
DNA oxidation in cortex and hippocampus following TBI in each age group that
increased in an age dependent format. This is the first study to evaluate oxidative damage
in TBI in aging. Lipid peroxidation is the consequence of oxidative damage to
polyunsaturated fatty acids, leading to formation of aldehydic byproducts that modify
proteins and DNA and lead to further damage to cell. DNA damage can lead to gene
mutations and affect transcription and protein expression, leading to alteration in normal
cellular function. Because the animal model used in current study mimics human TBI,
our results suggest oxidative damage may also happen in human brain. Additionally, the
data described in the dissertation showed an age-dependent increase of lipid peroxidation
following TBI, which could lead to aged neurons more fragile than young neurons.
The increase of oxidative damage and its age-dependent changes following TBI
suggest cellular defenses toward oxidative damage may be compromised following TBI
and are probably affected by age. So we measured the antioxidant enzyme activities
following TBI. We measured MnSOD, Cu/ZnSOD, GPx, GSSG-R, and GST activities,
enzymes that play different rules at different stages in cellular defense. MnSOD and
Cu/ZnSOD convert superoxide to hydrogen peroxide, and GPx converts hydroperoxides
and to alcohols or water. GSSG-R helps to maintain the reduced glutathione pool, and
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GST can detoxify xenobiotics and endogenously produced aldehydes, including lipid
peroxidation byproducts. Since MnSOD is located in mitochondria where most ROS are
produced, it is probably more important than other enzymes. Small changes in this
enzyme may lead to mitochondrial damage by superoxide and compromise ATP
production, leading to energy shortage in cells. Because most biological reactions are
ATP dependent, the ATP shortage could slow down or shut down most biological
process, leading to cell dysfunction. We observed significant decrease of MnSOD in
cortex following injury with aged animals showing more pronounced loses than young
adults. In the hippocampus, young animals maintained MnSOD activity until 24 h post
injury, and decreased 7 days post injury. But for middle aged and aged animals, MnSOD
decreased significantly beginning 24 h post injury. These results suggest aged animals
may have diminished capacities to remove superoxide leading to increased damage in
mitochondria. Cu/ZnSOD decreased in cortex 24 h and 7 days post injury. The decrease
of Cu/ZnSOD activity suggests damage in oxidative defense in cytoplasm. It is
interesting to note that MnSOD activity changed earlier than Cu/ZnSOD in hippocampus,
and decreased at 7 days post injury but Cu/ZnSOD did not. It is possible that oxidative
damage begins in mitochondria and spreads to cytosol. In cortex, young animals showed
a loss of Cu/ZnSOD activity 24 h post injury, and middle aged and aged animals showed
decreased Cu/ZnSOD 7 days post injury. MnSOD activity did not change in young
animals 24 h post injury, and decreased 7 days post injury, suggesting different responses
in cortex and hippocampus.
In cells subjected to oxidative damage, mitochondria are thought to be critical
important as the major source of ROS. Our data show a significant loss of MnSOD
following TBI. An understanding of mitochondrial changes following TBI may help yield
clues for TBI treatment. For example, with an understanding of what is going on in
neuronal mitochondria following TBI, it might be possible to target mitochondria in
patient treatment. In order to investigate changes in mitochondria following TBI, we
carried out studies of mitochondrial protein. Our data show mitochondrial protein
expression changes in cortex and hippocampus at 1 h and 24 h post injury. This is the
first study to examine how mitochondrial protein changes in isolated mitochondria
following TBI. An early time point (1 h) was selected for this study because previous
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studies from other labs showed early changes in mitochondria following TBI. We used
the isotope-coded affinity tag (ICAT) method to label mitochondrial proteins, and
following protein trypsinization and peptide purification, peptides were sequenced and
quantified using 2D LC/MS/MS. ICAT analysis of mitochondria from cortex and
hippocampus showed different responses to injury. Proteins or polypeptides of proteins
from the respiratory chain, and TCA cycle and channel proteins decreased significantly in
cortex 24 h post injury. In contrast, increased protein levels were observed in
hippocampus at this time point in both IP and CON hippocampus. A decrease of complex
I to complex V polypeptides in cortical mitochondria could lead to deficiencies of there
complexes, and an increase of ROS leakage, reducing the proton gradient and ATP
synthesis. ROS leakage could damage unsaturated fatty acids and the enzymes in
mitochondria, including MnSOD, leading to increased oxidative damage in cytosol.
Decreased levels of shuttle proteins for NADH transport from the cytosol to mitochondria
could lead to shortages of NADH in mitochondria for the electron transport chain.
Additionally, deficiencies in the TCA cycle following TBI could result in increased
NADH shortages. Voltage gated channel proteins function to regulate permeability of
outer membrane of mitochondria, and the observed decrease of their expression levels in
cortex could compromise metabolite exchanges between cytosol and mitochondria,
including ATP and calcium. These changes in mitochondria following TBI could shut
down mitochondrial function, leading to neuron dysfunction or death by triggering
apoptosis or necrosis. In the hippocampus, an increase of TCA enzymes could increase
NADH synthesis for the respiratory chain, and increased electron transport. However, we
observed one polypeptide, NADH-ubiquinone reductase B18 subunit that was
significantly decreased. Although function of this protein is unclear, the deviation of its
levels from normal may diminish the respiratory chain. Channel protein and heat shock
protein expression levels increase 24 h post injury in hippocampus. The increase of
VDAC protein could increase the permeability of outer membrane of mitochondria and
speed up metabolite and ion exchange between cytosol and mitochondria, and increase
the response to calcium following injury. Although previous studies by Lifshitz eta al.
(2003) showed mitochondrial shape changes and damage to the respiratory chain in
hippocampus following fluid percussion injury, our data showed protein levels increase
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in mitochondria. Hall et al. (2006) showed increased oxidative damage in mitochondria
following TBI. It is possible that oxidative damage in mitochondria lead to mitochondrial
deficits even though increased mitochondrial proteins. For future studies, we want to
elucidate why the mitochondrial protein expression changes following TBI and how
oxidative damage affects individual proteins in mitochondria.
The data described in this dissertation showed oxidative damage and changes in
mitochondrial proteins following TBI, and these could lead to neuron dysfunction. We
observed compromised antioxidant capacity in our study. If we can find a method to
reduce oxidative damage through increased antioxidant defenses and protect
mitochondria following TBI, it could be very helpful in the recovery of TBI patients.
Creatine is an endogenously synthesized small molecule in liver and kidney, and
is released to blood stream in human and other mammals. Creatine can cross the blood
brain barrier through a specific creatine transporter CRT, so its possible creatine may be a
good candidate drug to reduce oxidative damage and protect mitochondria. Clinical
studies in muscle disease showed creatine did not show side effects on patients (Felber et
al., 2000). Previous studies have shown oral or intracerebroventricular creatine to be
neuroprotective in PD, ALS, spinal cord injury and TBI. Pilot study carried out with 34
patients from 1 to 18 years old showed creatine was beneficial to TBI patients with no
side effects observed in an oral administration at a dose of 0.4 gr/kg (Sakellaris et al.,
2006). The administration of creatine to TBI patients improved patients in several
aspects, including duration of post-traumatic amnesia, duration of intubation, intensive
care unit stay, disability, general recovery, self care, communication, locomotion,
sociability, personality/behavior and neurophysical, and cognitive functions. Significant
improvement was recorded in the categories of cognitive, personality/behavior, self care,
and communication. Unfortunately, the mechanism by which creatine is unclear. To
determine if creatine can reduce oxidative damage, we provided animals a creatine
enriched diet prior to injury. The results described in this dissertation showed animals
with creatine supplementation had significantly reduced lipid peroxidation following
TBI. But how does creatine work to reduce oxidative damage? Further studies showed
SOD increased in animals with a creatine diet. GSSG-R and GST also increased in IP
tissues of animals with creatine supplementation. So we believe creatine can reduce
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oxidative damage through increased antioxidant defenses, thus protect neurons. Of
course, further studies are needed to elucidate how creatine administration affects
antioxidant enzyme activity.
Altogether, creatine, an endogenously synthesized small molecule, showed
benefitial function in primary clinical studies with small populations of patients. Previous
studies in other research groups show creatine can protect mitochondria through
regulation of MTP. Our data show creatine can reduce oxidative damage by increased
antioxidant enzyme activities. This is the first study to evaluate how creatine affects
antioxidant defense in vivo. This new study improved our understanding the function of
creatine, and further approved the beneficial effects of creatine supplementation to
patients with brain injury. We believe creatine may be a potential therapeutic for TBI
patients. Although, more clinical studies are needed, including post injury treatment
studies, pharmaceutical studies for the optimum dose.
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Appendix
Nomenclature
Abbreviations: AD, Alzheimer’s disease; ALS, amyotrophic lateral sclerosis; CON,
contralateral; Cu/ZnSOD, copper/zinc superoxide dismutase; FA, fapyadenine; FG,
fapyguanine; GPx, glutathione peroxidase; GSSG-R, glutathione reductase; GST,
glutathione transferase; HNE, 4-hydroxynonenal; IP, ipsilateral; ROS, reactive oxygen
species; MnSOD, manganese superoxide dismutase; PD, Parkinson’s disease; TBI,
traumatic brain injury; MPT, mitochondrial permeability transition; 8-OHG, 8hydroxyhuanine; 8-OHA, 8-hydroxyaenine; 5-OHC, 5-hydroxycytosine; CCI, cortical
controlled injury
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